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Introduction
Recent advances in genomic technology have allowed the
efﬁcient, large-scale characterization of gene copy-number
variation in the human genome (Emanuel and Saitta
2007; Beaudet and Belmont 2008; Korbel et al. 2008).
Copy-number variants and polymorphisms, which can
involve from one to dozens of genes, are increasingly
being linked with human diseases (Sharp et al. 2006;
McCarroll and Altshuler 2007), including neurodevelop-
mental conditions such as autism (Sebat et al. 2007) and
schizophrenia (Cantor and Geschwind 2008; Mulle 2008),
and they are currently the subject of intense interest from
medical geneticists. An important role for genomic copy-
number variation in human evolution has also been
postulated (Dumas et al. 2007), given that about one-
third of over 24 000 genes analyzed have been found to
exhibit copy-number variation among species of humans
and other primates (Dumas et al. 2007), with humans
and chimpanzees in particular differing by over 6% in
their complements of genes (Demuth et al. 2006). How-
ever, the roles of selection and other processes in the evo-
lution of such differences have only recently come under
scrutiny (Nguyen et al. 2006, 2008; Cooper et al. 2007;
Bonnefont et al. 2008; Korbel et al. 2008), and such evo-
lutionary-genomic studies have yet to focus on neuro-
genetic conditions underlain by variation in gene copy
number.
A key feature of gene copy-number variation is that it
normally engenders both deletions and duplications of the
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Abstract
Genomic sister-disorders are deﬁned here as diseases mediated by duplications
versus deletions of the same region. Such disorders can provide unique infor-
mation concerning the genomic underpinnings of human neurodevelopment
because effects of diametric variation in gene copy number on cognitive and
behavioral phenotypes can be inferred. We describe evidence from the litera-
ture on deletions versus duplications for the regions underlying the best-known
human neurogenetic sister-disorders, including Williams syndrome, Velocar-
diofacial syndrome, and Smith–Magenis syndrome, as well as the X-chromo-
somal conditions Klinefelter and Turner syndromes. These data suggest that
diametric copy-number alterations can, like diametric alterations to imprinted
genes, generate contrasting phenotypes associated with autistic-spectrum and
psychotic-spectrum conditions. Genomically based perturbations to the devel-
opment of the human social brain are thus apparently mediated to a notable
degree by effects of variation in gene copy number. We also conducted the ﬁrst
analyses of positive selection for genes in the regions affected by these disor-
ders. We found evidence consistent with adaptive evolution of protein-coding
genes, or selective sweeps, for three of the four sets of sister-syndromes
analyzed. These studies of selection facilitate identiﬁcation of candidate genes
for the phenotypes observed and lend a novel evolutionary dimension to the
analysis of human cognitive architecture and neurogenetic disorders.
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copy or three copies of the genes involved, in addition to
the usual complement of two (Stankiewicz and Lupski
2002; Redon et al. 2006; Sharp et al. 2006; Beckmann et al.
2007). Such variation provides unique opportunities to
analyze the phenotypic effects of variation in copy num-
ber, with naturally occurring variants that may generate
reduced, normal, and increased gene expression (or other
effects), depending upon the nature of the alterations
involved (e.g., Somerville et al. 2005; Meechan et al. 2007;
Stranger et al. 2007; Molina et al. 2008; Buchanan and
Scherer 2008). Similarly, variation in copy number for
an entire chromosome is represented by Turner syndrome
(45,X females) in comparison to Klinefelter syndrome
(usually 47,XXY). In this case, the aneuploidies may cause
variable expression of genes not subject to X inactivation,
which comprise the two pseudoautosomal regions and 15–
20% of other X-linked genes (Carrel and Willard 2005).
Diametric variation in gene copy number can generate
what can be referred to as ‘sister’-disorders, pairs of dis-
orders that are mediated by directly opposite alterations
to genomic regions that may result in diametric changes
to gene expression or transcriptional-regulation patterns.
In principle, sister-disorders might be expected to result
in diametric phenotypes to the extent that genotype–
phenotype mappings are relatively simple functions of gene
copy number and diametric alterations to developmental-
genetic pathways; for example, Bi et al. (2007) reported
hypoactivity versus hyperactivity in mice with the RAI1
gene experimentally deleted versus duplicated.
Genomic and developmental alterations due to gene
copy-number variation are directly analogous to diamet-
ric, large-magnitude effects due to alterations of
imprinted genes, which are usually expressed from only
one chromosome but when dysregulated may exhibit
either doubled or absent expression (Sha 2008). Genes
subject to imprinting effects are expected from the kin-
ship theory of imprinting to be involved in physiological
and social–behavioral interactions between mothers and
developing offspring (Haig 2004), and dysregulation of
such systems, toward increased relative effects from either
maternal or paternal genes, can mediate the development
of psychotic-spectrum versus autistic-spectrum conditions
respectively (Crespi and Badcock 2008). Alterations to
genomic copy number and to imprinted gene expression
may thus both lead, by different mechanisms, to large-
scale, diametric changes to neurodevelopment that may
provide useful insights into the genomic architecture of
psychiatric disorders involving the social brain.
The purpose of this review is to synthesize recent data
and compare the major human neurogenetic sister-disor-
ders recognized and characterized to date, to assess the
extent to which they exhibit diametric phenotypes with
regard to aspects of cognition and behavior. To achieve
this goal, we have synthesized two main sources of infor-
mation from the literature: (i) data on the phenotypes
associated with the four best-known human genomic sis-
ter-disorders, and (ii) data on linkages of the genes
involved to psychiatric conditions. We also conducted the
ﬁrst tests of positive selection (adaptive evolution) for the
genes salient to these syndromes, under the hypothesis
that positively selected genes or haplotypes in these
regions have, historically, exhibited functional phenotypic
effects on neurodevelopment, cognition and behavior that
make them especially strong positional and functional
candidates for the causes of variation in social–cognitive
phenotypes observed across pairs of sister-disorders.
Examples of genes exhibiting variants that affect cognition
and psychiatric phenotypes, as well as showing evidence
for recent positive selection in humans, include FOXP2
(Enard et al. 2002), EFHC2 (Weiss et al. 2007), and
MCPH1 (Evans et al. 2005; Lencz et al. 2007a), as well as
positively selected genes underlying schizophrenia (Crespi
et al. 2007). Most generally, this study is intended to
facilitate the integration of evolutionary principles and
methods into analyses of the genetic and genomic bases
for human neurocognitive disorders and the architecture
of nonclinical cognitive and behavioral phenotypes.
Methods
Literature review
PubMed and Web of Science were searched using the
names of speciﬁc known syndromes, and the terms ‘dele-
tion’ and ‘duplication’ in conjunction with the names,
genomic locations, and genes associated with the syn-
dromes analyzed. Psychiatric and behavioral phenotypes
associated with these syndromes and regions were
searched using syndrome names, genomic regions, and
genes, in conjunction with the names of the major psy-
chiatric conditions. We also used the schizophrenia gene
database (Allen et al. 2008) and Sullivan laboratory evi-
dence project database (Konneker et al. 2008), to collect
and synthesize evidence regarding the genetic bases of
psychiatric phenotypes.
Analyses of positive selection
We used two measures of positive selection for the genes
involved in the neurogenetic syndromes analyzed here:
the iHS statistic developed by Voight et al. (2006), which
quantiﬁes the probabilities of recent selective sweeps
for given genes and regions of the genome from human
HapMap data, and the branch-site likelihood ratio tests
of branch-site models implemented in PAML (Zhang
et al. 2005), which allows inference of adaptive protein
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et al. (2007), and we tested for selection along the human
lineage, the human–chimp stem lineage, and the lineage
at the origin of primates (the ancestral primate lineage
leading to Catarhinni, including Old World monkeys, les-
ser apes and great apes), as these lineages exhibit pheno-
typic changes that we consider most salient to the
evolution of social cognition.
Results
The primary genetic, genomic, and phenotypic features of
the syndromes analyzed here are summarized in Tables 1
and 2. We describe each pair of sister-syndromes, sum-
marize the evidence for positive selection on the genes
involved, and synthesize the available information.
Smith–Magenis and Potocki–Lupski syndromes
Smith–Magenis syndrome is caused by a microdeletion of
about 3.7 Mb at 17p11.2, or by mutations in the gene
RAI1 (retinoic acid inducible 1), the gene believed to
underlie most of the behavioral, neurological and cranio-
facial traits found in this condition (Smith et al. 2005;
Bi et al. 2006; Girirajan et al. 2006; Elsea and Girirajan
2008) (Table 1). Potocki–Lupski syndrome, due to dupli-
cation of this same region, has recently been identiﬁed
and described (Potocki et al. 2007) and it appears to be
due predominantly to increased copy number of RAI1
(Molina et al. 2008).
Smith–Magenis syndrome
Behavioral and cognitive characteristics that have
been described for Smith–Magenis syndrome include
generalized complacency and lethargy in infancy, speech
delay, stereotypies that involve self-hugging and ‘licking
and ﬂipping’ the pages of books, hyperactivity, impulsiv-
ity, aggression, self-injury, skin picking, mood lability, and
a friendly, affectionate personality (Shelley and Robertson
2005; Smith et al. 2005; Girirajan et al. 2006; Martin et al.
2006; Gropman et al. 2007). Traits ascribed to this condi-
tion also include a high level of social attention-seeking
and friendliness with strangers, high sensitivity and irrita-
bility (Sarimski 2004), decreased sensitivity to pain (Shelley
and Robertson 2005; Bi et al. 2006), high sociability as
infants, with appealing smiles and lack of crying, and good
eye contact and sense of humor as children (Smith et al.
1998). Individuals with Smith–Magenis syndrome exhibit
moderate to severe mental retardation (Sarimski 2004),
with a relative strength in verbal skills, but relatively weak
sequential processing abilities (Dykens et al. 1997).
The psychiatric phenotypes associated with Smith–
Magenis syndrome include a case report of ‘mood disor-
der’ involving extreme mood shifts, depression and
‘explosive behavior’ (Bersani et al. 2007), a case report of
Tourette’s syndrome (Shelley et al. 2007), and three cases
of Smith–Magenis syndrome due to RAI1 point muta-
tions that involved ‘bipolar episodes’ in two individuals,
and ‘explosive tantrums’ in another. Genome-scan studies
have linked the 17p11.2 region with a variety of disorders,
including schizophrenia (Williams et al. 2003; Bulayeva
et al. 2005, 2007), attention-deﬁcit/hyperactivity disorder
(ADHD) (Ogdie et al. 2003) and autism (Trikalinos et al.
2006; Ylisaukko-oja et al. 2006), and cytogenetic anoma-
lies of this region have been associated with autism
(Lauritsen et al. 1999; Vorstman et al. 2006). Variation in
the number of CAG repeats in the RAI1 gene has been
linked with drug responses in schizophrenics, but these
variants were not associated with schizophrenia itself
(Joober et al. 1999). However, polymorphisms in the two
Table 1. Genomic sister-disorders of human growth, development, cognition and behavior, with descriptions of their genetic bases.
Syndrome name or description Primary genomic alteration and genes implicated
Smith–Magenis Hemizygous deletion of region at 17p11.2 including RAI1 gene; RAI1 mutations (Gropman et al. 2007)
Potocki–Lupski Duplication of Smith–Magenis region (Potocki et al. 2007)
VCFS region deletion Deletion of 30 genes at 22q11.2, effects from COMT, DGCR2, GNB1L, TBX1, UFD1L, other genes
(Gothelf 2007; Meechan et al. 2007)
VCFS region duplication Duplication of 22q11.2 region (Mukaddes and Herguner 2007)
Williams-syndrome region
deletion
Hemizygous deletion of over 25 genes at 7q11.23; effects from CYLN2, GTF2I, GTF2IRD1, LIMK1,
other genes (Tassabehji 2003; Gray et al. 2006; Edelmann et al. 2007; Young et al. 2008)
Williams-syndrome region
duplication
Duplication of 7q11.23 region (Berg et al. 2007)
Klinefelter One or more excess X chromosomes; Increased expression of PAR1, PAR2 genes and other non
X-inactivated genes (DeLisi et al. 2005; Vawter et al. 2007)
Turner All or part of X chromosome lost (Sybert and McCauley 2004); haploinsufﬁciency of PAR1, PAR2
genes and other non X-inactivated genes (Lynn and Davies 2007); neurocognitive phenotype
maps to Xp22.3 (Zinn et al. 2007)
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and SREBF1, have recently been linked with schizophrenia
(Liu et al. 2007; Le Hellard et al. 2008).
Potocki–Lupski syndrome
Potocki–Lupski syndrome is characterized by failure
to thrive in infancy, developmental delay, speech
Table 2. Genomic sister-disorders categorized into two groups, each of which shares a suite of partially overlapping phenotypic traits.
Psychotic-spectrum syndromes Autistic-spectrum syndromes
Smith–Magenis Potocki–Lupski
High levels of sociability (Smith et al. 1998;
Sarimski 2004)
High rates of autism and autistic behavior (Moog et al. 2004;
Potocki et al. 2007)
Relative strength in verbal skills (Dykens et al. 1997)
Case reports of ‘bipolar episodes’ (Girirajan et al. 2006)
Case report of mood disorder (Bersani et al. 2007)
Velocardiofacial Velocardiofacial-region duplications
Better verbal than visual–spatial skills
(Bearden et al. 2001;
Lajiness-O’Neill et al. 2006)
Hyperactivity, attention deﬁcits, anxiety, depression, seizures,
speech problems, impulsivity (Ensenauer et al. 2003; Yobb et al.
2005; Alberti et al. 2007)
High rates of schizophrenia, schizoaffective disorders, bipolar,
depression, anxiety, phobia (Gothelf 2007)
Case report of autism (Mukaddes and Herguner 2007)
Case report of Asperger syndrome (Hassed et al. 2004b)
Two cases of autism (Marshall et al. 2008)
Two cases of autism (Christian et al. 2008)
Williams Williams-region duplications
Better verbal than visual–spatial skills
(Vicari et al. 2004)
Severe language impairment, visual-spatial skills spared
(Berg et al. 2007)
Hypersociability, fascination with faces
(Doyle et al. 2004)
High rates of autism and autistic behavior (Berg et al. 2007;
Depienne et al. 2007)
Dyslexia (Temple 2006)
High rates of anxiety and phobias (Meyer-Lindenberg et al. 2006;
Lincoln et al. 2007)
Klinefelter Turner
Dyslexia (Geschwind et al. 2000) Hyperlexia (Temple and Carney 1996)
Poor verbal skills, preserved visual- spatial skills
(Money 1993; DeLisi et al. 2005)
Good verbal skills, impaired visual- spatial skills (Money 1993;
Kesler 2007)
High rates of schizophrenia, schizoaffective disorder, schizotypy,
bipolar disorder, anxiety, depression (DeLisi et al. 2005; van Rijn
et al. 2005; Boks et al. 2007)*
Gaze aversion (Lawrence et al. 2003)
High rates of autism and autistic traits in maternal-X cases (Skuse
et al. 1997)
Reduced incidence of schizophrenia plus bipolar disorder (Mors
et al. 2001)
Idiopathic schizophrenia Idiopathic autism
Low birth weight (Wahlbeck et al. 2001;
Nilsson et al. 2005)
High or average birth weight (Sacco et al. 2007; Mraz et al. 2007;
Sugie et al. 2005)
Slow growth (Niemi et al. 2005)
Small head, brain size (Gur et al. 2007)
Overgrowth, faster body growth (Dissanayake et al. 2006; Mills
et al. 2007; Mraz et al. 2007; Fukumoto et al. 2008)
Better verbal than visual–spatial skills (Kravariti et al. 2006) Macrocephaly (Lainhart et al. 2006; Stanﬁeld et al. 2008)
Dyslexia (Bersani et al. 2006; Revheim et al. 2006) Hyperlexia (Newman et al. 2007)
Overlap in genetic basis with bipolar disorder, major depression,
and schizotypy (Craddock and Forty 2006; Van Den Bogaert et al.
2006; Blackwood et al. 2007; Fanous et al. 2007; Potash 2006
Better visual–spatial than verbal skills in subset of cases (Caron
et al. 2006)
‘Psychotic-spectrum’ syndromes involve an increased incidence of psychotic-spectrum psychiatric conditions (mainly schizophrenia, schizoaffective
disorder, bipolar disorder, depression, anxiety, and phobias), and ‘autistic-spectrum’ syndromes involve autistic traits, autism and Asperger
syndrome.
*Two case studies have described autism or autism-spectrum disorders (PDD-NOS) in Klinefelter individuals (Jha et al. 2007; Merhar and Manning-
Courtney 2007). These cases were characterized by speech delay and introversion, with no evidence of restricted interests or motor stereotypies
in the four children described.
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of heard speech), verbal apraxia, mild mental retardation,
autistic features, epileptiform EEG, seizures, and hyperac-
tivity (Girirajan et al. 2007; Potocki et al. 2007). Two
individuals with this syndrome were formally diagnosed
with autism (Moog et al. 2004; Potocki et al. 2007), and
speciﬁc autistic features that have been described include
decreased eye contact, motor mannerisms, sensory hyper-
sensitivities or preoccupations, and repetitive behavior
(Potocki et al. 2007). Potocki et al. (2007) suggested that
nearly all patients with this syndrome exhibited features
of autism spectrum disorders.
Evidence of positive selection
Using PAML, the RAI1 gene was inferred as subject to
positive selection for the primate-origin lineage (Table 3),
but not in the human or human–chimp lineages, nor in
the human HapMap data.
Synthesis
Smith–Magenis and Potocki–Lupski syndromes are clear
genomic sister-disorders that appear to exhibit diametric
phenotypes with regard to sociability and verbal abilities.
Although Potocki–Lupski syndrome is strongly associated
with autism, the behavioral phenotype and psychiatric
correlates of Smith–Magenis syndrome have yet to be
analyzed systematically, although they appear to involve
high levels of sociability and a high incidence of dysregu-
lated mood. The presence of positive selection for the
RAI1 gene in the primate-origin lineage is notable given
that only seven of 120 randomly chosen ‘control’ genes
involved in neurological functions have shown evidence
of selection on this lineage (Crespi et al. 2007).
Velocardiofacial syndrome and duplications of the VCFS
region
Velocardiofacial syndrome (VCFS) involves congenital
malformation of the heart, face and limbs, usually due to
a 3-Mb deletion at 22q11.2 that contains over 30 genes
(Feinstein et al. 2002; Maynard et al. 2002; Gothelf 2007;
Kobrynski and Sullivan 2007; Gothelf et al. 2008; Prasad
et al. 2008). A syndrome mediated by duplication of this
region has recently been recognized, and is being better-
characterized as more cases accumulate (Table 2).
Velocardiofacial syndrome
Velocardiofacial syndrome involves mild mental retarda-
tion, impaired language development, motor skills, and
verbal working memory, and especially limited abilities in
reading comprehension, visual–spatial tasks and mathe-
matics, in contrast to relatively well-preserved verbal skills
(Bearden et al. 2001; Niklasson et al. 2001; Simon et al.
2005a,b; Zinkstok and van Amelsvoort 2005; Lajiness-
O’Neill et al. 2006). The behavioral phenotype of VCFS
patients in childhood and early adolescence involves with-
drawal, shyness, impulsiveness, inattentiveness (Dykens
et al. 2000), emotional lability, angry outbursts, and high
Table 3. Evidence for positive selection on genes associated with human neurogenetic sister-disorders, from maximum likelihood analyses.
Gene Gene symbol Lineage )2DLn
Positively selected codons
(posterior probability)
Pseudoautosomal region 1
Interleukin 3 receptor, alpha IL3RA Primate 5.32* None
GTP binding protein 6 GTPBP6 Primate 8.04** Leu 125 (0.982)
Acetylserotonin O-methyltransferase-like ASTML Primate 6.20* None
Purinergic receptor P2Y, G-protein coupled, 8 P2R8Y Primate 9.82** None
Velocardiofacial syndrome
claudin 5 CLDN5 Primate 6.70** None
Guanine nucleotide binding protein, beta polypeptide 1-like GNB1L Primate 4.86* Ser 119 (0.961)
Zinc ﬁnger protein 74 ZNF74 Primate 9.94** Ala 84 (0.961)
Thr 321 (0.991)
Catechol-O-methyltransferase COMT Primate 8.02** Pro 324 (0.972)
Ubiquitin fusion degradation 1 like UFD1L Human 6.58* His 221 (0.983)
Smith–Magenis syndrome
Retinoic acid induced 1 RAI1 Primate 5.68* None
Williams syndrome
Replication factor C 2 RFC2 Primate 3.78 None
We focused on putatively causative genes where these were known from studies of single-gene mutations or atypical deletions (in Williams syn-
drome and Smith–Magenis syndrome), but where the causative genes were unknown (for Klinefelter, Turner, and Velocardiofacial syndromes) we
analyzed all of the genes in the affected regions.
*P < 0.05, **P < 0.01.
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and anxiety, depression, social withdrawal and psychotic
episodes (mainly auditory hallucinations) (Debbane ´ et al.
2006). In adolescence and adulthood, about 30% of VCFS
patients are diagnosed with schizophrenia, of a form with
a relatively high incidence of positive symptoms (Murphy
2002; Vogels et al. 2002). This syndrome thus represents
the most common genetic alteration known to mediate
risk of schizophrenia (Bassett and Chow 2008), and one
of the most penetrant causes of schizophrenia. VCFS also
demonstrates notable similarities to schizophrenia in
overall neurocognitive proﬁle (Chow et al. 2006; Lewan-
dowski et al. 2007), and brain structure in VCFS appears
similar to that found in schizophrenia in some respects
(Gothelf et al. 2007a,b, 2008). Gothelf (2007) describes
the wider psychopathological proﬁle of VCFS patients, as
involving high rates of schizophrenia and schizoaffective
disorder, bipolar disorder, depression, dysthymia, pho-
bias, obsessive–compulsive disorder, generalized anxiety
disorder, panic disorder, ADHD, pervasive developmental
disorder – not otherwise speciﬁed (PDD-NOS), and psy-
chotic symptoms. VCFS has also been associated with
autism spectrum conditions (e.g., Antshel et al. 2007;
Kates et al. 2007), but such diagnoses appear to be based
on superﬁcial psychological similarities of autism or
PDD-NOS with schizotypy and negative symptoms
of schizophrenia, that are not underlain by biological
evidence (Eliez 2007; Feinstein and Singh 2007; Crespi
and Badcock 2008; Sugihara et al. 2008).
Many of the physical features of VCFS are apparently
mediated by haploinsufﬁciency of the TBX1 gene (Paylor
et al. 2006; Zweier et al. 2007), and several genes in the
deletion region, notably COMT, DGCR2, GNB1L,
ProDH2, UFD1L have been implicated in liability to
schizophrenia among individuals without VCFS syndrome
(Liu et al. 2002; Antshel et al. 2005; Gothelf et al. 2005;
Wonodi et al. 2005; Shifman et al. 2006; Allen et al. 2008;
Prasad et al. 2008; Williams et al. 2008). Given that over
30 genes are commonly deleted in this syndrome, the
physical and psychiatric phenotypes appear to be medi-
ated by reduced expression of multiple genes, whose rela-
tive importance for different phenotypes remains to be
elucidated (Meechan et al. 2007).
VCFS-region duplications
About 30 cases of duplications of the VCFS region have
thus far been reported (Mukaddes and Herguner 2007).
These duplications are associated with phenotypes that
include some combination of hyperactivity, attention deﬁ-
cits, learning disability, speech delays, impulsivity, sei-
zures, and aggressive behavior (Hassed et al. 2004a;
Portnoı ¨ et al. 2005; Yobb et al. 2005; Alberti et al. 2007;
Mukaddes and Herguner 2007). This condition appears
milder, more variable, and less distinctive than VCFS (de
La Rochebrochard et al. 2006; Courtens et al. 2008; Ou
et al. 2008), and it has not been ascertained indepen-
dently of other conditions, although the duplication was
found in two of 275 females referred for fragile X testing
(Yobb et al. 2005).
Mukaddes and Herguner (2007) presented a case report
of severe autism associated with this duplication, with
minimal speech, stereotypic behavior, and lack of eye
contact, joint attention or play; the father of this patient
exhibited the same duplication, and was described as
introverted, obsessive and learning disabled. Hassed et al.
(2004b) diagnosed a case of Asperger syndrome in an
individual with this region duplicated, and Marshall et al.
(2008) and Christian et al. (2008) each reported two cases
of autistic individuals with the duplication. Although
schizophrenia risk is increased 30-fold in 22q11.2 dele-
tion cases, a recent study reported no cases of 22q11.2
duplications in a sample of 190 patients with schizophre-
nia (Brunet et al. 2008).
Evidence of positive selection
Maximum-likelihood analyses detected four genes (of 29
analyzed) in the 3 Mb typically deleted VCFS region as
subject to positive selection in the primate-origin lineage
(Table 3). This proportion of genes inferred as selected
(13.8%) is higher than the proportion selected (5.8%) on
this lineage among 120 ‘control’ neurological-function
genes (Crespi et al. 2007) but not signiﬁcantly so
(v
2 = 2.16, P = 0.14). One gene, UFD1L, showed evidence
of selection along the human lineage. Of the ﬁve total
genes inferred as selected with maximum likelihood, four
of them (CLDN5, COMT, GNB1L, and UFD1L) have
been associated with schizophrenia in one or more study
(Allen et al. 2008; Williams et al. 2008).
Genes showing HapMap evidence of selection
(P < 0.05 in one or more of the three populations) in
recent human ancestry include DGCR6 and a block of
contiguous genes spanning HIRA, MRPL40, UFD1L,
CDC45L, and CLDN5, with the former four of these
genes showing evidence of selection for all three popula-
tions, which is very rare for HapMap-based selection
studies (Voight et al. 2006).
Synthesis
Velocardiofacial syndrome is strongly associated with
schizophrenia and related disorders, and the genetic and
neuroanatomical correlates of these conditions. The phe-
notypes associated with VCFS-duplication syndrome are
only now emerging, and robust evaluation of the behav-
ioral and psychiatric features in this syndrome requires
standardized study of a substantial number of cases.
However, the association of autism with VCFS-region
Genomic sister-disorders Crespi et al.
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motivate analyses that further evaluate the presence of
autism-associated biological traits (such as macrocephaly
and seizures) and well as cognitive proﬁles and formal
DSM criteria.
Three lines of evidence: (i) the notable proportion of
VCFS-region genes inferred as subject to positive selec-
tion for the primate-origin lineage, (ii) the HapMap
selection signal across a block of genes in three
populations, and (iii) the ﬁnding that one schizophre-
nia-associated gene, UFD1L, shows evidence of positive
selection for the human lineage from both HapMap and
PAML analyses, suggest that some of the genes underly-
ing the phenotypic effects of VCFS have undergone
primate-speciﬁc and human-speciﬁc adaptive evolution
with functional relevance to the etiologies of schizophre-
nia and autism.
Williams syndrome and Williams-syndrome region
duplications
Williams syndrome is typically caused by deletion of a
region of 7q11.23 that includes 25–30 genes (Tassabehji
2003), although analyses of atypical deletions have shown
that a small subset of these genes is sufﬁcient to elicit the
main phenotypic traits involved. This deletion is mediated
by low-copy-repeats that ﬂank this region (Antonell et al.
2005), which also cause duplications that have recently
been identiﬁed and characterized with regard to their
phenotypic effects (Berg et al. 2007; Depienne et al. 2007;
Kirchhoff et al. 2007).
Williams syndrome
Williams syndrome is characterized by a suite of behav-
ioral and cognitive features that include hypersociality
and inappropriate social engagement of strangers, fascina-
tion with faces and enhanced gazing into faces, hyperver-
bal speech with a relative strength in vocabulary and
social–emotional language, increased empathy and acute
attentiveness to the emotional states of others, and
increased attention-seeking and affectionate behavior (Po-
ber and Dykens 1996; Doyle et al. 2004; Feinstein and
Singh 2007; Fidler et al. 2007; Porter et al. 2007; Martens
et al. 2008).
Expressive language has been considered to be a nota-
ble relative strength in Williams syndrome, although the
degree to which aspects of this trait are selectively
enhanced, relative to IQ-matched controls, remains
unclear (Meyer-Lindenberg et al. 2006; Brock 2007).
However, verbal skills are clearly much better than
visual–spatial abilities, which are selectively and strongly
deﬁcient (Tager-Flusberg and Sullivan 2000; Reiss et al.
2004; Vicari et al. 2004; Porter and Coltheart 2005). The
overall cognitive proﬁle of Williams syndrome has been
described as similar to that found in VCFS, especially
with regard to visual–spatial deﬁcits but relatively spared
verbal skills (Bearden et al. 2002).
Williams syndrome is also characterized by a set of
behavioral and cognitive phenotypes related to psychiatric
disorders, although few studies have addressed the issue
of formal diagnoses of such disorders. Thus, Pober and
Dykens (1996) noted high levels of anxiety, worry,
preoccupation, crying and fearfulness, as well as depres-
sive symptoms, in Williams syndrome individuals, and
Dykens (2003), Leyfer et al. (2006) and Meyer-Lindenberg
et al. (2006) describe substantially elevated rates of
anxiety and phobias. In a study of 4–18 years olds, about
50% of individuals met DSM criteria for speciﬁc phobia
(Leyfer et al. 2006) and frequencies of diagnosis were also
high for ADHD (65%) and generalized anxiety disorder
(12%).
The presence of autism spectrum disorders in Williams
syndrome is controversial (Lincoln et al. 2007; Riby and
Hancock 2008). There have been several case reports of
autism diagnoses in individuals with this syndrome
(Herguner and Mukaddes 2006; Klein-Tasman et al.
2007), and both conditions can involve impaired prag-
matics of language, unusual interests, impaired develop-
ment of pointing and gesturing, and difﬁculties in
forming and maintaining social relationships (Laws and
Bishop 2004; Fidler et al. 2007; Klein-Tasman et al. 2007).
However, theory of mind skills has been reported as com-
parable to matched controls in Williams syndrome, and
levels of empathy appear to be elevated above controls
(Sullivan and Tager-Flusberg 1999; Tager-Flusberg and
Sullivan 2000). These ﬁndings, and such traits as fascina-
tion with faces and selective attention to social stimuli in
Williams syndrome (Jones et al. 2000; Mervis et al. 2003),
and the relative strengths in visual–spatial skills reported
for autistics (Caron et al. 2004, 2006), have motivated the
hypothesis that Williams syndrome and autism represent
neurocognitive opposites (Peterson and Panksepp 2004).
These views can be reconciled by considering the usual
Williams syndrome neurocognitive proﬁle as involving a
mosaic of behavioral traits, some of which are not
uncommon on the autism spectrum while others are
strikingly nonautistic (Lincoln et al. 2007).
Neuroanatomical contrasts between idiopathic autism
and Williams syndrome that may be relevant to neuro-
cognition include overall brain size smaller in Williams
syndrome (Chiang et al. 2007) but larger on average in
autism (e.g., Sacco et al. 2007), disproportionate reduc-
tions in white matter in Williams syndrome (Reiss et al.
2000) but increases in autism (Herbert et al. 2004), and a
cerebellar vermis that is larger in Williams syndrome
(Schmitt et al. 2001) but smaller in autism (Kaufmann
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ism and other psychiatric disorders in Williams syndrome
is the presence, in the region that directly ﬂanks the typi-
cal deletion and may show reduced gene expression as an
apparent result (Merla et al. 2006), of the AUTS2 gene,
which exhibits mutations and a breakpoint associated
with mental retardation and autism (Kalscheuer et al.
2007), and an SNP, D7S1816, strongly linked to lithium-
responsive bipolar disorder in a genome scan (Turecki
et al. 2001). This latter ﬁnding is of notable interest given
that social impulsiveness and disinhibition, mediated in
part by orbitofrontal cortex abnormalities, represent a
prominent phenotype in both bipolar disorder and Wil-
liams syndrome (Altshuler et al. 2005; Meyer-Lindenberg
et al. 2005; Porter et al. 2007). One gene in the Williams-
syndrome region, STX1A, exhibits genetic variants that
have been associated with schizophrenia (Wong et al.
2004); moreover, elevated expression of the STX1A gene,
as well as a positive genetic association, has been reported
for autism (Nakamura et al. 2008).
Genes in the Williams syndrome region that appear to
be associated with core aspects of its neurocognitive pro-
ﬁle, based on genotype–phenotype associations of vari-
able-size deletions, mouse mutants for speciﬁc genes, and
knowledge of gene function, include CYLN2, Gtf2I,
Gtf2IRD1, and LIMK1 (Hoogenraad et al. 2004; Gray
et al. 2006; Edelmann et al. 2007; Young et al. 2008).
Taken together, these studies suggest that several genes
are involved, and affect different cognitive features of
Williams syndrome: reduced copy-number of Gft2RD1
has been implicated in decreased fear and increased social
behavior in a mouse model (Young et al. 2008), LIMK1
hemizygous mice exhibit impairments in spatial abilities
(Meng et al. 2002), and both CYLN2 and LIMK1 hemizy-
gous mice exhibit impaired learning (Hoogenraad et al.
2004).
Williams syndrome-region duplications
Berg et al. (2007) reviewed the phenotypic features of
the 10 individuals reported thus far with duplications of
the Williams syndrome region, who were ascertained by
developmental delays. Weight, growth and length were
highly variable, but three of seven individuals measured
were at or above 90% percentile in head circumference;
three of 10 individuals also exhibited seizures. All 10
cases involved severe to moderate speech delay and
mental retardation, but visual–spatial abilities were
reported as spared in the ﬁve individuals evaluated for
this phenotype (Berg et al. 2007). Four of seven individ-
uals with behavioral information available showed
stereotyped or repetitive behavior, and two of four
individuals administered the ADOS met or exceeded the
cutoff for ASD or autism. In previous case studies,
Kirchhoff et al. (2007) reported a case of ‘suspected
Asperger syndrome’, and Depienne et al. (2007) reported
a case of autism identiﬁed from screening 206 patients
with autism spectrum disorders for this duplication.
Among cases described to date, Orellana et al. (2008)
noted striking variability in phenotype, including good
social skills in several individuals, but severe language
delay as a highly consistent symptom.
Evidence of positive selection
None of the seven genes analyzed spanning GTF2It o
LIMK1 demonstrated statistical signiﬁcance in maximum-
likelihood analyses, although RFC2 showed borderline
nonsigniﬁcance (0.05 < P < 0.06) for the primate-origin
lineage (Table 3). None of the genes showed gene-wide
evidence of selection in the HapMap analyses. Haploin-
sufﬁciency of RFC2 causes impaired ATR-mediated DNA
damage response in Williams-syndrome cell lines, indicat-
ing that this gene may be responsible in part for
the microcephaly and developmental delays found in
Williams syndrome (O’Driscoll et al. 2007).
Synthesis
Somerville et al. (2005) and Berg et al. (2007) noted that
the contrasting effects of deletions versus duplications
for the Williams syndrome region provide evidence for
strong effects of quantitative gene dosage variation on
human language, sociality, and visual–spatial abilities.
Expressive language in particular appears to be relatively
spared (compared to other cognitive functions) in
Williams syndrome deletions, but it is strikingly
impaired in individuals with duplications for this region.
The genetic basis of these contrasting phenotypes
remains unclear, but to the extent that the variation in
gene expression of GTF2IRD1 modulates the observed
effects on social–behavioral phenotypes in humans and
mice (Young et al. 2008), it represents a strong func-
tional candidate as a gene whose over-expression can
cause autism and associated deﬁcits in the development
of language. Our inference of possible selection on the
RFC2 gene also suggests that this gene, thus far
neglected in studies of Williams syndrome, may play a
role in the evolution of primate neurodevelopment,
brain size evolution, and in the etiology of this
syndrome.
X chromosome aneuploidies
The most common human disorders involving sex
chromosome are Turner syndrome (usually 45,X, or a
mosaic of 45,X and 46,XX) in females (Good et al. 2003;
Rovet 2004), and Klinefelter syndrome (usually 47,XXY)
in males (Simpson et al. 2003) (Table 1). Phenotypic
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chromosome are also mediated by whether genes are
X-inactivated: genes in both pseudoautosomal regions of
the X, and about 15–20% of other genes on this chromo-
some, are not X-inactivated (Carrel and Willard 2005),
and should thus exhibit variable expression levels between
45,X, 46,XX, 46,XY, and 47,XXY individuals.
Turner syndrome (45,X)
The neurocognitive proﬁle of adults with Turner syn-
drome is characterized by three main features: (i) normal
or enhanced verbal skills, especially with regard to reading
level, accuracy and comprehension, including a relatively
high incidence of hyperlexia, (ii) notable impairments of
visual–spatial skills as assayed, for example, via tests of
mental rotation, block design, object assembly and mathe-
matical ability, and (iii) impaired social skills (Money
1993; Temple and Carney 1996; Lawrence et al. 2003;
Nijhuis-van der Sanden et al. 2003; Molko et al. 2004;
Temple 2006; Kesler 2007).
In addition to the traits described above, the behavioral
proﬁle of Turner syndrome females also involves high
rates of impulsivity, hyperactivity and inattentiveness
(Russell et al. 2006), and social anxiety (Kesler 2007).
Turner syndrome females also commonly exhibit a set of
behavioral and neurocognitive phenotypes including poor
peer relationships, joint attention deﬁcits, and reduced
ability to interpret social cues (Donnelly et al. 2000), gaze
aversion (Lawrence et al. 2003) and impaired recognition
of fear (Lawrence et al. 2003; Weiss et al. 2007). This
syndrome has also been reported to involve a signiﬁcantly
lower incidence of schizophrenia and bipolar disorder
(considered together) (Mors et al. 2001) and a greatly
increased risk of autism (Skuse et al. 1997; Skuse 2000,
2005).
Klinefelter syndrome (47,XXY)
Klinefelter syndrome is associated with infantile hypoto-
nia, hypogonadism, cryptorchidism, low birth weight,
reduced length, and small head size, but increased adult
height (Varrela 1984; Ratcliffe et al. 1990, 1994; Brandes
and Mesrobian 2005; Ross et al. 2005; Giedd et al. 2007).
The neurocognitive proﬁle of Klinefelter syndrome is
characterized by selective impairment of verbal abilities,
especially in language processing, reading, and working
verbal memory, with visual–spatial abilities relatively
spared (Graham et al. 1988; Geschwind et al. 2000; Boone
et al. 2001; Fales et al. 2003; Itti et al. 2003, 2006; Simp-
son et al. 2003; DeLisi et al. 2005). Money (1993)
described this proﬁle as the neurocognitive opposite of
that found in Turner syndrome, with the core deﬁcit in
Klinefelter syndrome attributable to impaired ‘mental
processing of sequence and synchrony in the temporal
dimension, including the temporal dimension of lan-
guage’ and Boone et al. (2001) suggested that such verbal,
left-hemisphere deﬁcits are related to slow early brain
development.
Psychiatric conditions associated with Klinefelter syn-
drome include anxiety, depression, bipolar disorder,
schizoaffective disorder and schizophrenia (Mizukami
et al. 1989; DeLisi et al. 1994, 2005; Everman and Stoude-
mire 1994; van Rijn et al. 2005, 2006; Boks et al. 2007).
Several studies have demonstrated that schizophrenia in
particular shows a high prevalence in Klinefelter
syndrome, with a four- to 10-fold increase (DeLisi et al.
1994, 2005; van Rijn et al. 2006). In contrast, Mors et al.
(2001) reported similar rates of schizophrenia and bipolar
disorder in Klinefelter syndrome compared to controls,
and they attributed the results of DeLisi et al. (1994) to
unspeciﬁed sampling biases. DeLisi et al. (2005) also
noted that the neurocognitive proﬁles are similar in
Klinefelter syndrome and idiopathic (cause-unknown)
schizophrenia, and van Rijn et al. (2006) showed that
Klinefelter individuals scored signiﬁcantly higher than
controls on scales of schizotypy. Klinefelter syndrome also
involves an uneven proﬁle of hyperfunctional emotional
experience and reactivity, but impaired ability to identify
and verbalize emotions, which resembles the pattern seen
in schizophrenics (van Rijn et al. 2005, 2006).
Genetic basis of sex-chromosome aneuploidy phenotypes
The Turner syndrome neurocognitive phenotype of
visual–spatial deﬁcits with preserved or enhanced verbal
skills has been mapped to Xp22.3, in pseudoautosomal
region 1 (PAR1) (Ross et al. 2006; Zinn et al. 2007).
A strong positional and functional candidate for a gene
in this region underlying at least one aspect of the Turner
syndrome neurocognitive phenotype, and the contrasting
pattern in Klinefelter syndrome of verbal deﬁcits but
spared visual–spatial abilities, has been identiﬁed by
Vawter et al. (2007). These authors compared gene
expression in 47,XXY versus 46,XY individuals, and found
that the gene GTPBP6, in PAR1 at Xp22.33, exhibited
signiﬁcantly higher expression in 47,XXY males, and that
within Klinefelter patients, higher expression of this gene
was associated with signiﬁcantly reduced verbal skills.
The altered rates of schizophrenia and autism in
individuals with sex chromosome aneuploidies implicate
the effects of non-inactivated X-linked genes, or XY
homologous genes, in these disorders. This hypothesis is
supported by recent linkage of two loci in PAR1 (and the
Turner syndrome neurocognitive region) with these
neurodevelopmental disorders: the CSF2RA-IL3RA locus
shows allelic variants associated with schizophrenia (Lencz
et al. 2007b; Sun et al. 2008), and the ASMT gene bears
variants associated with autism (Melke et al. 2008).
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We used maximum-likelihood analyses to test for positive
selection on 20 genes in PAR1, as this region has been
implicated in the phenotypic effects of Turner and Kline-
felter syndromes. Positive selection was inferred for four
genes, ASMTL, GTPBP6, IL3RA, and P2RY8, all on the
primate-origin lineage (Table 3). This proportion of genes
inferred as selected (20%) is signiﬁcantly higher than the
proportion selected (5.8%) on this lineage among 120
‘control’ neurological-function genes (Crespi et al. 2007)
(v
2 = 5.03, P = 0.025).
Synthesis
Turner syndrome and Klinefelter syndrome demonstrate a
clear diametric contrast with regard to verbal and visual–
spatial skills, with Turner syndrome characterized by
good verbal skills but greatly impaired visual–spatial abili-
ties and Klinefelter syndrome individuals impaired ver-
bally but with visual–spatial abilities spared (Money 1993;
DeLisi et al. 2005). These syndromes also involve notably
different associations with psychiatric disorders, as Turner
syndrome individuals exhibit an elevated incidence of
autism and autistic traits, but Klinefelter syndrome
involves increased rates of schizophrenia and related dis-
orders. The localization of genetic effects on verbal skills,
visual–spatial skills, and some psychiatric disorders
to non-inactivated X-linked genes suggest that altered
dosages of such genes underlie the contrasting neurocog-
nitive phenotypes of Turner and Klinefelter syndromes.
These ﬁndings have important implications for the evolu-
tion of sexual dimorphism as well as the developmental
and neurological bases of neurogenetic syndromes, as
non-inactivated X-linked genes are expected to differ in
dosage between males and females (Craig et al. 2004;
Davies and Wilkinson 2006; Crespi 2008a).
The inference of positive selection on PAR1-region genes
that inﬂuence verbal ability (GTPBP6, Vawter et al. 2007)
and schizophrenia risk (IL3RA, Lencz et al. 2007b; Sun
et al. 2008) is striking, especially given that IL3RA is the
only PAR1 gene thus far implicated in schizophrenia. The
function of the ASMTL gene remains unclear, but part of
this gene is highly homologous with the autism-associated
gene ASMT (Ried et al. 1998; Melke et al. 2008).
Discussion
Genomic sister-disorders provide unique opportunities to
assess the roles of gene copy-number variation in human
development and disease. For the set of neurogenetic
sister-disorders analyzed here, the clearest overall pattern
is that one of the pairs has been commonly associated
with autism spectrum conditions (Table 2), a ﬁnding that
concurs with the results of recent studies showing that a
notable proportion of cases of autism can be ascribed to
the effects of copy-number variants (Sebat et al. 2007;
Christian et al. 2008; Marshall et al. 2008; Mefford et al.
2008; Miller et al. 2008). In contrast, the sister-disorders
of the autism-associated conditions noted in Table 2
appear to involve a suite of phenotypic traits that are
characteristic of what has been termed the schizophrenia
spectrum or psychotic spectrum, which is exempliﬁed by
the set of psychological and psychiatric conditions
described for VCFS by Gothelf (2007, Table 2), as well as
for Klinefelter syndrome (Mizukami et al. 1989; Everman
and Stoudemire 1994; DeLisi et al. 2005; van Rijn et al.
2005, 2006; Boks et al. 2007); these conditions include
schizophrenia, schizoaffective disorder, bipolar disorder,
unipolar depression, schizotypy, phobias, generalized
anxiety disorder, panic disorders, and psychotic symp-
toms. The former ﬁve conditions have been demonstrated
to exhibit strong patterns of overlap with regard to their
genetic underpinnings (Craddock and Forty 2006; Potash
2006; Van Den Bogaert et al. 2006; Blackwood et al. 2007;
Fanous et al. 2007), and rates of comorbidity of anxiety
and phobias with schizophrenia, schizoaffective disorder,
and bipolar disorder are on the order of 40–60% (Cosoff
and Hafner 1998; Huppert and Smith 2005; Zutshi et al.
2006). As for autism, the etiology of schizophrenia is
mediated, to a notable degree, by copy-number variation
across a considerable number of genomic regions (Cantor
and Geschwind 2008; Mulle 2008).
The inference that pairs of neurogenetic sister-disorders
tend to involve autistic-spectrum versus psychotic-spec-
trum phenotypes implies that human cognitive architec-
ture may be structured along a continuum of social brain
development from hypo-development in autism, to
so-called normality, to hyper-development in psychosis,
which is revealed most clearly by diametric perturbations
to genes affecting development and evolution of the social
brain (Crespi and Badcock 2008). Evidence of such a pat-
tern has also been reported for perturbations that involve
genomic imprinting, which are expected under the kin-
ship theory of imprinting (Haig 2004) to involve social
interactions and social brain development (Crespi 2008b;
Crespi and Badcock 2008). The pattern for copy-number
effects described here suggests that not only relatively
well-known neurogenetic sister-disorders, but also
disorders due to smaller-scale and less well-characterized
copy-number polymorphisms or variants, may mediate
similarly contrasting cognitive and psychiatric phenotypes.
More generally, primate and human evolution has
presumably involved the selective accumulation of
alleles mediating development of an increasingly complex
and sophisticated social brain, which in humans may
be perturbed toward either hypo-development in
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psychotic-spectrum conditions, where language, causal
thinking, social emotionality, and self-consciousness are
speciﬁcally dysregulated (Burns 2004; Crow 2008; Crespi
and Badcock 2008).
The primary caveat regarding our interpretation of these
data on neurogenetic sister-disorders is that some genomic
alterations, such as VCFS duplications and Williams-syn-
drome region duplications, involve variable phenotypes
that have yet to be characterized thoroughly in terms of
behavioral phenotypes (Feinstein and Singh 2007), or cate-
gorized in relation to formal psychiatric conditions. More-
over, the behavioral phenotypes of Smith–Magenis
syndrome and Williams syndrome involve high levels of
sociability, which contrast with notable levels of autistic
spectrum phenotypes in their respective duplications but
require further study to evaluate in terms of psychotic spec-
trum conditions such as phobias and mood lability. Further
analyses of neurogenetic sister-disorders might usefully
focus on dissecting genotype–phenotype correlations in
such cases, also taking account of potentially causative vari-
ability in patterns of gene expression (e.g., Meechan et al.
2007). An important consideration for such studies is the
presence of superﬁcial psychological similarities between
autism and some manifestations of schizophrenia (such as
childhood premorbid phenotypes and negative symptoms)
that are not underlain by clearly shared biological causes
and may thus obfuscate interpretation of phenotypes in
terms of psychiatric conditions (Feinstein and Singh 2007;
Crespi 2008b; Crespi and Badcock 2008; Gothelf et al.
2008; Sugihara et al. 2008; see also Kates et al. 2007). Such
similarities are especially problematic in studies of pediatric
populations (e.g., Mefford et al. 2008; Weiss et al. 2008),
given that children premorbid for schizophrenia spectrum
conditions commonly exhibit deﬁcits in social phenotypes
(e.g., McClellan et al. 2003) that can lead to incorrect diag-
noses of autism.
To the extent that individuals with diametric genomic
alterations exhibit diametric phenotypes, the genes mediat-
ing these phenotypes can be identiﬁed and characterized
using a variety of methods including analyses of atypical
deletions and single-gene mutations, mouse mutants, asso-
ciation studies relating variation in speciﬁc genes to salient
traits, and studies of gene function and expression levels
(e.g., Girirajan et al. 2008). In this study, we have analyzed
how the salient genes have evolved along the lineages lead-
ing to humans and other primates, and detected the signals
of positive selection on a notable number of the genes that
are duplicated or deleted in neurogenetic sister-disorders.
Based on combined information from studies of genetics,
development, mouse models, and positive selection, several
genes, including GTPBP6, IL3RA, RAI1, and UFD1L, can
be highlighted as especially strong candidates for single
genes whose altered expression may mediate the develop-
ment of autistic and psychotic spectrum conditions, and
social cognition more generally. To the extent that genes
such as these have been subject to selection in the context
of lower or higher levels of expression during primate
evolution (e.g., Khaitovich et al. 2006), their altered
expression may thus be especially likely, compared to other
genes, to cause maladaptive effects on neurodevelopment
that affect social–behavioral phenotypes. This hypothesis is
amenable to further study via analyses of the molecular
and phenotypic effects of haplotypes or amino acids
inferred as selected. Our ﬁnding that positive selection was
especially prominent along the primate-origin lineage
suggests that molecular-evolutionary changes underlying
important features of complex social cognition were estab-
lished well before separation of the human lineage. This
hypothesis is consistent with complex patterns of genomic
copy-number change in primates for PAR1 (Helena Mangs
and Morris 2007), the VCFS region (Shaikh et al. 2000;
Babcock et al. 2007), and the Williams-syndrome region
(Antonell et al. 2005), and with ﬁndings from comparative
primatology (e.g., Zuberbu ¨hler 2006), but it requires
more-detailed comparative-genomic analyses.
Most generally, our study shows that how evolutionary
perspectives and tools can provide novel insights into the
genetic bases of human neurodevelopment and cognitive
architecture, and complement studies based in psychiatry,
neuroscience, and molecular and disease genetics. In par-
ticular, studies of positive selection can highlight genes or
genomic regions with potential functional effects on med-
ically relevant phenotypes, and models of cognitive archi-
tecture, derived from inferences regarding the evolution
of human sociality, can structure the interpretation of
psychiatric phenotypes and the search for their proximate
causes. Such insights from evolutionary biology are based
on integration of two large research areas, the evolution
of humans and the etiology of human neurogenetic
conditions, that have thus far developed in considerable
isolation.
Acknowledgements
C. Feinstein, U. Franke and R. Weksberg kindly provided
useful comments on earlier versions of this paper. This
work was funded by grants from NSERC and the Canada
Council for the Arts to B. C., an ECU College Research
Award to K. S., and an NIH Ruth L. Kirschstein National
Research Service Award to S. D.
Literature cited
Alberti, A., C. Romano, M. Falco, F. Calı `, P. Schinocca,
O. Galesi, A. Spalletta et al. 2007. 1.5 mb de novo 22q11.21
Crespi et al. Genomic sister-disorders
ª 2009 The Authors
Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100 91microduplication in a patient with cognitive deﬁcits and
dysmorphic facial features. Clinical Genetics 71:177–182.
Allen, N. C., S. Bagade, M. B. McQueen, J. P. A. Ioannidis,
F. K. Kavvoura, M. J. Khoury, R. E. Tanzi et al. 2008.
Systematic meta-analyses and ﬁeld synopsis of genetic
association studies in schizophrenia: the SzGene database.
Nature Genetics 40:827–834.
Altshuler, L. L., S. Y. Bookheimer, J. Townsend, M. A. Proen-
za, N. Eisenberger, F. Sabb, J. Mintz et al. 2005. Blunted
activation in orbitofrontal cortex during mania: a functional
magnetic resonance imaging study. Biological Psychiatry
58:763–769.
Antonell, A., O. de Luis, X. Domingo-Roura, and L. A. Pe ´rez-
Jurado. 2005. Evolutionary mechanisms shaping the genomic
structure of the Williams-Beuren syndrome chromosomal
region at human 7q11.23. Genome Research 15:1179–1188.
Antshel, K. M., W. R. Kates, N. Roizen, W. Fremont, and
R. J. Shprintzen. 2005. 22q11.2 deletion syndrome: genetics,
neuroanatomy and cognitive/behavioral features keywords.
Child Neuropsychology 11:5–19.
Antshel, K. M., A. Aneja, L. Strunge, J. Peebles, W. P. Fre-
mont, K. Stallone, N. Abdulsabur et al. 2007. Autistic
spectrum disorders in velo-cardio-facial syndrome (22q11.2
deletion). Journal of Autism and Developmental Disorders
37:1776–1786.
Babcock, M., S. Yatsenko, J. Hopkins, M. Brenton, Q. Cao,
P. de Jong, P. Stankiewicz et al. 2007. Hominoid lineage
speciﬁc ampliﬁcation of low-copy repeats on 22q11.2
(LCR22s) associated with velo-cardio-facial/digeorge
syndrome. Human Molecular Genetics 16:2560–2571.
Baker, K. D., and D. H. Skuse. 2005. Adolescents and young
adults with 22q11 deletion syndrome: psychopathology in an
at-risk group. British Journal of Psychiatry 186:115–120.
Bassett, A. S., and E. W. C. Chow. 2008. Schizophrenia and
22q11.2 deletion syndrome. Current Psychiatry Reports
10:148–157.
Bearden, C. E., M. F. Woodin, P. P. Wang, E. Moss,
D. McDonald-McGinn, E. Zackai, B. Emannuel et al. 2001.
The neurocognitive phenotype of the 22q11.2 deletion syn-
drome: selective deﬁcit in visual-spatial memory. Journal of
Clinical and Experimental Neuropsychology 23:447–464.
Bearden, C. E., P. P. Wang, and T. J. Simon. 2002. Williams
syndrome cognitive proﬁle also characterizes Velocardiofa-
cial/DiGeorge syndrome. American Journal of Medical
Genetics 114:689–692.
Beaudet, A. L., and J. W. Belmont. 2008. Array-based DNA
diagnostics: let the revolution begin. Annual Review of Med-
icine 59:113–129.
Beckmann, J. S., X. Estivill, and S. E. Antonarakis. 2007. Copy
number variants and genetic traits: closer to the resolution
of phenotypic to genotypic variability. Nature Reviews.
Genetics 8:639–646.
Berg, J. S., N. Brunetti-Pierri, S. U. Peters, S. L. Kang, C. Fong,
J. Salamone, D. Freedenberg et al. 2007. Speech delay and
autism spectrum behaviors are frequently associated with
duplication of the 7q11.23 Williams-Beuren syndrome
region. Genetics in Medicine 9:427–441.
Bersani, G., M. L. Maneschi, E. Tarolla, and P. Pancheri.
2006. Dyslexia as a possible aspect of neurocognitive
impairment in schizophrenia. Schizophrenia Research
82:265–266.
Bersani, G., D. Russo, L. Limpido, and D. Marconi. 2007.
Mood disorder in a patient with Smith-Magenis syndrome:
a case report. Neuroendocrinology Letters 28:7–10.
Bi, W., G. M. Saiﬁ, S. Girirajan, X. Shi, B. Szomju, H. Firth,
R. E. Magenis et al. 2006. RAI1 point mutations, CAG
repeat variation, and SNP analysis in non-deletion Smith-
Magenis syndrome. American Journal of Medical Genetics.
Part A 140:2454–2463.
Bi, W., J. Yan, X. Shi, L. A. Yuva-Paylor, B. A. Antalffy,
A. Goldman, J. W. Yoo et al. 2007. Rai1 deﬁciency in mice
causes learning impairment and motor dysfunction, whereas
Rai1 heterozygous mice display minimal behavioral pheno-
types. Human Molecular Genetics 16:1802–1813.
Blackwood, D. H. R., B. J. Pickard, P. A. Thomson,
K. L. Evans, D. J. Porteous, and W. J. Muir. 2007. Are some
genetic risk factors common to schizophrenia, bipolar disor-
der and depression? Evidence from DISC1, GRIK4 and
NRG1. Neurotoxicity Research 11:73–83.
Boks, M. P. M., M. H. T. de Vette, I. E. Sommer, S. van Rijn,
J. C. Giltay, H. Swaab, and R. S. Kahn. 2007. Psychiatric
morbidity and X-chromosomal origin in a Klinefelter
sample. Schizophrenia Research 93:399–402.
Bonnefont, J., S. I. Nikolaev, A. L. Perrier, S. Guo, L. Cartier,
S. Sorce, T. Laforge et al. 2008. Evolutionary forces shape
the human RFPL1,2,3 genes toward a role in neocortex
development. American Journal of Human Genetics 83:
208–218.
Boone, K. B., R. S. Swerdloff, B. L. Miller, D. H. Geschwind,
J. Razani, A. Lee, I. G. Gonzalo et al. 2001. Neuropsycho-
logical proﬁles of adults with Klinefelter syndrome.
Journal of the International Neuropsychological Society
7:446–456.
Brandes, B. M., and H. O. Mesrobian. 2005. Evaluation and
management of genital anomalies in two patients with
Klinefelter syndrome and review of literature. Urology
65:976–979.
Brock, J. 2007. Language abilities in Williams syndrome:
a critical review. Development and Psychopathology 19:97–
127.
Brunet, A., L. Armengol, T. Pelaez, R. Guillamat, V. Valles, E.
Gabau, X. Estivill et al. 2008. Failure to detect the 22q11.2
duplication syndrome among patients with schizophrenia.
Behavioral and Brain Functions 4:10.
Buchanan, J. A., and S. W. Scherer. 2008. Contemplating
effects of genomic structural variation. Genetics in Medicine
10:639–647.
Bulayeva, K. B., S. M. Leal, T. A. Pavlova, R. M. Kurbanov,
S. J. Glatt, O. A. Bulayev, and M. T. Tsuang. 2005. Mapping
genes of complex psychiatric diseases in Daghestan genetic
Genomic sister-disorders Crespi et al.
ª 2009 The Authors
92 Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100isolates. American Journal of Medical Genetics. Part B,
Neuropsychiatric Genetics 132:76–84.
Bulayeva, K. B., S. J. Glatt, O. A. Bulayev, T. A. Pavlova, and
M. T. Tsuang. 2007. Genome-wide linkage scan of schizo-
phrenia: a cross-isolate study. Genomics 89:167–177.
Burns, J. K. 2004. An evolutionary theory of schizophrenia:
cortical connectivity, metarepresentation, and the social
brain. Behavioral and Brain Sciences 27:831–855.
Cantor, R. M., and D. H. Geschwind. 2008. Schizophrenia:
genome, interrupted. Neuron 58:165–167.
Caron, M.-J., L. Mottron, C. Rainville, and S. Chouinard.
2004. Do high functioning persons with autism present
superior spatial abilities? Neuropsychologia 42:467–481.
Caron, M.-J., L. Mottron, C. Berthiaume, and M. Dawson.
2006. Cognitive mechanisms, speciﬁcity and neural
underpinnings of visuospatial peaks in autism. Brain
129:1789–1802.
Carrel, L., and H. F. Willard. 2005. X-inactivation proﬁle
reveals extensive variability in X-linked gene expression in
females. Nature 434:400–404.
Chiang, M., A. L. Reiss, A. D. Lee, U. Bellugi, A. M. Gala-
burda, J. R. Korenberg, D. L. Mills et al. 2007. 3D pattern of
brain abnormalities in Williams syndrome visualized using
tensor-based morphometry. Neuroimage 36:1096–1109.
Chow, E. W. C., M. Watson, D. A. Young, and A. S. Bassett.
2006. Neurocognitive proﬁle in 22q11 deletion syndrome
and schizophrenia. Schizophrenia Research 87:270–278.
Christian, S. L., C. W. Brune, J. Sudi, R. A. Kumar, S. Liu, S.
Karamohamed, J. A. Badner, et al. 2008. Novel submicro-
scopic chromosomal abnormalities detected in autism spec-
trum disorder. Biological Psychiatry 63:1111–1117.
Cooper, G. M., D. A. Nickerson, and E. E. Eichler. 2007.
Mutational and selective effects on copy-number variants in
the human genome. Nature Genetics 39:22–29.
Cosoff, S. J., and R. J. Hafner. 1998. The prevalence of comor-
bid anxiety in schizophrenia, schizoaffective disorder and
bipolar disorder. Australian and New Zealand Journal of
Psychiatry 32:67–72.
Courtens, W., I. Schramme, and A. Laridon. 2008. Microdupli-
cation 22q11.2: a benign polymorphism or a syndrome with
a very large clinical variability and reduced penetrance? –
Report of two families. American Journal of Medical Genet-
ics. Part A 146:758–763.
Craddock, N., and L. Forty. 2006. Genetics of affective (mood)
disorders. European Journal of Human Genetics 14:660–668.
Craig, I. W., E. Harper, and C. S. Loat. 2004. The genetic basis
for sex differences in human behaviour: role of the sex chro-
mosomes. Annals of Human Genetics 68:269–284.
Crespi, B. J. 2008a. Turner syndrome and the evolution of
human sexual dimorphism. Evolutionary Applications 1:
449–461.
Crespi, B. J. 2008b. Genomic imprinting in the development
and evolution of psychotic spectrum conditions. Biological
Reviews 83:441–493.
Crespi, B., and C. Badcock. 2008. Psychosis and autism as
diametrical disorders of the social brain. Behavioral and
Brain Sciences 31:241–320.
Crespi, B., K. Summers, and S. Dorus. 2007. Adaptive evolu-
tion of genes underlying schizophrenia. Proceedings of the
Royal Society of London, Series B. Biological Sciences
274:2801–2810.
Crow, T. J. 2008. The ‘big bang’ theory of the origin of psy-
chosis and the faculty of language. Schizophrenia Research
102:31–52.
Davies, W., and L. S. Wilkinson. 2006. It is not all hormones:
alternative explanations for sexual differentiation of the
brain. Brain Research 1126:36–45.
Debbane ´, M., B. Glaser, M. K. David, C. Feinstein, and S.
Eliez. 2006. Psychotic symptoms in children and adolescents
with 22q11.2 deletion syndrome: neuropsychological and
behavioral implications. Schizophrenia Research 84:187–193.
DeLisi, L. E., U. Friedrich, J. Wahlstrom, A. Boccio-Smith,
A. Forsman, K. Eklund, and T. J. Crow. 1994. Schizophrenia
and sex chromosome anomalies. Schizophrenia Bulletin
20:495–505.
DeLisi, L. E., A. M. Maurizio, C. Svetina, B. Ardekani, K.
Szulc, J. Nierenberg, J. Leonard et al. 2005. Klinefelter’s
syndrome (XXY) as a genetic model for psychotic disorders.
American Journal of Medical Genetics. Part B, Neuropsychi-
atric Genetics 135:15–23.
Demuth, J. P., T. De Bie, J. E. Stajich, N. Cristianini, and
M. W. Hahn. 2006. The evolution of mammalian gene fami-
lies. PLoS ONE 1:e85.
Depienne, C., D. Heron, C. Betancur, B. Benyahia, O. Trouil-
lard, D. Bouteiller, A. Verloes et al. 2007. Autism, language
delay and mental retardation in a patient with 7q11 duplica-
tion. Journal of Medical Genetics 44:452–458.
Dissanayake, C., Q. M. Bui, R. Huggins, and D. Z. Loesch.
2006. Growth in stature and head circumference in high-
functioning autism and Asperger disorder during the ﬁrst
3 years of life. Development and Psychopathology 18:381–
393.
Donnelly, S. L., C. M. Wolpert, M. M. Menold, M. P. Bass,
J. R. Gilbert, M. L. Cuccaro, G. R. Delong et al. 2000.
Female with autistic disorder and monosomy X (Turner
syndrome): parent-of-origin effect of the X chromosome.
American Journal of Medical Genetics 96:312–316.
Doyle, T. F., U. Bellugi, J. R. Korenberg, and J. Graham. 2004.
‘‘Everybody in the world is my friend’’ hypersociability in
young children with Williams syndrome. American Journal
of Medical Genetics. Part A. 124:263–273.
Dumas, L., Y. H. Kim, A. Karimpour-Fard, M. Cox,
J. Hopkins, J. R. Pollack, and J. M. Sikela. 2007. Gene copy
number variation spanning 60 million years of human and
primate evolution. Genome Research 17:1266–1277.
Dykens, E. M. 2003. Anxiety, fears, and phobias in persons
with Williams syndrome. Developmental Neuropsychology
23:291–316.
Crespi et al. Genomic sister-disorders
ª 2009 The Authors
Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100 93Dykens, E. M., B. M. Finucane, and C. Gayley. 1997. Brief
report: cognitive and behavioral proﬁles in persons with
Smith-Magenis syndrome. Journal of Autism and Develop-
mental Disorders 27:203–211.
Dykens, E. M., R. M. Hodapp, and B. M. Finucane. 2000.
Genetics and Mental Retardation Syndromes: A New Look
at Behavior and Interventions. Brookes Publishing Com-
pany, Baltimore, MD.
Edelmann, L., A. Prosnitz, S. Pardo, J. Bhatt, N. Cohen,
T. Lauriat, L. Ouchanov et al. 2007. An atypical deletion of
the Williams-Beuren syndrome interval implicates genes
associated with defective visuospatial processing and autism.
Journal of Medical Genetics 44:136–143.
Eliez, S. 2007. Autism in children with 22q11.2 deletion
syndrome. Journal of the American Academy of Child and
Adolescent Psychiatry 46:433–434.
Elsea, S. H., and S. Girirajan. 2008. Smith-Magenis syndrome.
European Journal of Human Genetics 16:412–421.
Emanuel, B. S., and S. C. Saitta. 2007. From microscopes to
microarrays: dissecting recurrent chromosomal rearrange-
ments. Nature Reviews. Genetics 8:869–883.
Enard, W., M. Przeworski, S. E. Fisher, C. S. L. Lai, V. Wiebe,
T. Kitano, A. P. Monaco et al. 2002. Molecular evolution of
FOXP2, a gene involved in speech and language. Nature
418:869–872.
Ensenauer, R. E., A. Adeyinka, H. C. Flynn, V. V. Michels,
N. M. Lindor, D. B. Dawson, E. C. Thorland et al. 2003.
Microduplication 22q11.2, an emerging syndrome: clinical,
cytogenetic, and molecular analysis of thirteen patients.
American Journal of Human Genetics 73:1027–1040.
Evans, P. D., S. L. Gilbert, N. Mekel-Bobrov, E. J. Vallender,
J. R. Anderson, L. M. Vaez-Azizi, S. A. Tishkoff et al. 2005.
Microcephalin, a gene regulating brain size, continues to
evolve adaptively in humans. Science 309:1717–1720.
Everman, D. B., and A. Stoudemire. 1994. Bipolar disorder
associated with Klinefelter’s syndrome and other chromo-
somal abnormalities. Psychosomatics 35:35–40.
Fales, C. L., B. J. Knowlton, K. J. Holyoak, D. H. Geschwind,
R. S. Swerdloff, and I. G. Gonzalo. 2003. Working memory
and relational reasoning in Klinefelter syndrome. Journal of
the International Neuropsychological Society 9:839–846.
Fanous, A. H., M. C. Neale, C. O. Gardner, B. T. Webb, R. E.
Straub, F. A. O’Neill, D. Walsh et al. 2007. Signiﬁcant
correlation in linkage signals from genome-wide scans of
schizophrenia and schizotypy. Molecular Psychiatry 12:958–
965.
Feinstein, C., and S. Singh. 2007. Social phenotypes in neuro-
genetic syndromes. Child and Adolescent Psychiatric Clinics
of North America 16:631–647.
Feinstein, C., S. Eliez, C. Blasey, and A. L. Reiss. 2002. Psychi-
atric disorders and behavioral problems in children with
velocardiofacial syndrome: usefulness as phenotypic indica-
tors of schizophrenia risk. Biological Psychiatry 51:312–318.
Fidler, D. J., S. L. Hepburn, D. E. Most, A. Philofsky, and
S. J. Rogers. 2007. Emotional responsivity in young children
with Williams syndrome. American Journal of Mental
Retardation 112:194–206.
Fukumoto, A., T. Hashimoto, H. Ito, M. Nishimura, Y. Tsuda,
M. Miyazaki, K. Mori et al. 2008. Growth of head
circumference in autistic infants during the ﬁrst year of
life. Journal of Autism and Developmental Disorders
38:411–418.
Geschwind, D. H., K. B. Boone, B. L. Miller, and R. S. Swerdl-
off. 2000. Neurobehavioral phenotype of Klinefelter
syndrome. Mental Retardation and Developmental
Disabilities Research Reviews 6:107–116.
Giedd, J. N., L. S. Clasen, G. L. Wallace, R. K. Lenroot,
J. P. Lerch, E. M. Wells, J. D. Blumenthal et al. 2007. XXY
(Klinefelter syndrome): a pediatric quantitative brain mag-
netic resonance imaging case-control study. Pediatrics
119:e232–e240.
Girirajan, S., C. N. Vlangos, B. B. Szomju, E. Edelman, C. D.
Trevors, L. Dupuis, M. Nezarati et al. 2006. Genotype-phe-
notype correlation in Smith-Magenis syndrome: evidence
that multiple genes in 17p11.2 contribute to the clinical
spectrum. Genetics in Medicine 8:417–427.
Girirajan, S., S. R. Williams, J. Y. Garbern, N. Nowak, E.
Hatchwell, and S. H. Elsea. 2007. 17p11.2p12 triplication
and del(17)q11.2q12 in a severely affected child with
dup(17)p11.2p12 syndrome. Clinical Genetics 72:47–58.
Girirajan, S., N. Patel, R. E. Slager, M. E. Tokarz, M. Bucan,
J. L. Wiley, and S. H. Elsea. 2008. How much is too much?
phenotypic consequences of Rai1 overexpression in mice.
European Journal of Human Genetics 16:941–954.
Good, C. D., K. Lawrence, N. S. Thomas, C. J. Price,
J. Ashburner, K. J. Friston, R. S. J. Frackowiak et al. 2003.
Dosage-sensitive X-linked locus inﬂuences the development
of amygdala and orbitofrontal cortex, and fear recognition
in humans. Brain 126:2431–2446.
Gothelf, D. 2007. Velocardiofacial syndrome. Child and
Adolescent Psychiatric Clinics of North America 16:677–693.
Gothelf, D., S. Eliez, T. Thompson, C. Hinard, L. Penniman,
C. Feinstein, H. Kwon et al. 2005. COMT genotype predicts
longitudinal cognitive decline and psychosis in 22q11.2
deletion syndrome. Nature Neuroscience 8:1500–1502.
Gothelf, D., L. Penniman, E. Gu, S. Eliez, and A. L. Reiss.
2007a. Developmental trajectories of brain structure in
adolescents with 22q11.2 deletion syndrome: a longitudinal
study. Schizophrenia Research 96:72–81.
Gothelf, D., C. Feinstein, T. Thompson, E. Gu, L. Penniman,
E. Van Stone, H. Kwon et al. 2007b. Risk factors for the
emergence of psychotic disorders in adolescents with
22q11.2 deletion syndrome. American Journal of Psychiatry
164:663–669.
Gothelf, D., M. Schaer, and S. Eliez. 2008. Genes, brain devel-
opment and psychiatric phenotypes in velo-cardio-facial syn-
drome. Developmental Disabilities Research Reviews 14:59–
68.
Graham, J. M., A. S. Bashir, R. E. Stark, A. Silbert, and
S. Walzer. 1988. Oral and written language abilities of XXY
Genomic sister-disorders Crespi et al.
ª 2009 The Authors
94 Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100boys: implications for anticipatory guidance. Pediatrics
81:795–806.
Gray, V., A. Karmiloff-Smith, E. Funnell, and M. Tassabehji.
2006. In-depth analysis of spatial cognition in Williams syn-
drome: a critical assessment of the role of the LIMK1 gene.
Neuropsychologia 44:679–685.
Gropman, A. L., S. Elsea, W. C. Duncan, and A. C. M. Smith.
2007. New developments in Smith-Magenis syndrome (del
17p11.2). Current Opinion in Neurology 20:125–134.
Gur, R. E., M. S. Keshavan, and S. M. Lawrie. 2007. Decon-
structing psychosis with human brain imaging. Schizophre-
nia Bulletin 33:921–931.
Haig, D. 2004. Genomic imprinting and kinship: how good is
the evidence? Annual Review of Genetics 38:553–585.
Hassed, S. J., D. Hopcus-Niccum, L. Zhang, S. Li, and
J. J. Mulvihill. 2004a. A new genomic duplication syndrome
complementary to the velocardiofacial (22q11 deletion)
syndrome. Clinical Genetics 65:400–404.
Hassed, S., S. A. Vaz, J. Lee, J. J. Mulvihill, and S. Li. 2004b.
Expanded phenotype of the 22q duplication syndrome.
American Journal of Human Genetics 75(Suppl.):151.
Helena Mangs, A., and B. J. Morris. 2007. The human pseud-
oautosomal region (PAR): origin, function and future. Cur-
rent Genomics 8:129–136.
Herbert, M. R., D. A. Ziegler, N. Makris, P. A. Filipek, T. L.
Kemper, J. J. Normandin, H. A. Sanders et al. 2004.
Localization of white matter volume increase in autism and
developmental language disorder. Annals of Neurology
55:530–540.
Herguner, S., and N. M. Mukaddes. 2006. Autism and Wil-
liams syndrome: a case report. World Journal of Biological
Psychiatry 7:186–188.
Hoogenraad, C. C., A. Akhmanova, N. Galjart, and C. I. De
Zeeuw. 2004. LIMK1 and CLIP-115: linking cytoskeletal
deﬁcits to Williams syndrome. Bioessays 26:141–150.
Huppert, J. D., and T. E. Smith. 2005. Anxiety and schizophre-
nia: the interaction of subtypes of anxiety and psychotic
symptoms. CNS Spectrums 10:721–731.
Itti, E., I. T. Gaw Gonzalo, K. B. Boone, D. H. Geschwind,
N. Berman, A. Pawlikowska-Haddal, L. Itti et al. 2003. Func-
tional neuroimaging provides evidence of anomalous cere-
bral laterality in adults with Klinefelter’s syndrome. Annals
of Neurology 54:669–673.
Itti, E., I. T. Gaw Gonzalo, A. Pawlikowska-Haddal, K. B.
Boone, A. Mlikotic, L. Itti, F. S. Mishkin et al. 2006. The
structural brain correlates of cognitive deﬁcits in adults with
Klinefelter’s syndrome. Journal of Clinical Endocrinology
and Metabolism 91:1423–1427.
Jha, P., D. Sheth, and M. Ghaziuddin. 2007. Autism spectrum
disorder and Klinefelter syndrome. European Child &
Adolescent Psychiatry 16:305–308.
Jones, W., U. Bellugi, Z. Lai, M. Chiles, J. Reilly, A. Lincoln,
and R. Adolphs. 2000. II. Hypersociability in Williams syn-
drome. Journal of Cognitive Neuroscience 12(Suppl. 1):30–
46.
Joober, R., C. Benkelfat, A. Toulouse, R. G. Lafrenie `re, S. Lal,
S. Ajroud, G. Turecki et al. 1999. Analysis of 14 CAG
repeat-containing genes in schizophrenia. American Journal
of Medical Genetics 88:694–699.
Kalscheuer, V. M., D. FitzPatrick, N. Tommerup, M. Bugge,
E. Niebuhr, L. M. Neumann, A. Tzschach et al. 2007. Muta-
tions in autism susceptibility candidate 2 (AUTS2) in
patients with mental retardation. Human Genetics 121:
501–509.
Kates, W. R., K. M. Antshel, W. P. Fremont, R. J. Shprintzen,
L. A. Strunge, C. P. Burnette, and A. M. Higgins. 2007.
Comparing phenotypes in patients with idiopathic autism to
patients with velocardiofacial syndrome (22q11 DS) with
and without autism. American Journal of Medical Genetics.
Part A. 143:2642–2650.
Kaufmann, W. E., K. L. Cooper, S. H. Mostofsky,
G. T. Capone, W. R. Kates, C. J. Newschaffer, I. Bukelis
et al. 2003. Speciﬁcity of cerebellar vermian abnormalities in
autism: a quantitative magnetic resonance imaging study.
Journal of Child Neurology 18:463–470.
Kesler, S. R. 2007. Turner syndrome. Child and Adolescent
Psychiatric Clinics of North America 16:709–722.
Khaitovich, P., W. Enard, M. Lachmann, and S. Pa ¨a ¨bo. 2006.
Evolution of primate gene expression. Nature Reviews.
Genetics 7:693–702.
Kirchhoff, M., A. Bisgaard, T. Bryndorf, and T. Gerdes. 2007.
MLPA analysis for a panel of syndromes with mental retar-
dation reveals imbalances in 5.8% of patients with mental
retardation and dysmorphic features, including duplications
of the Sotos syndrome and Williams-Beuren syndrome
regions. European Journal of Medical Genetics 50:33–42.
Klein-Tasman, B. P., C. B. Mervis, C. Lord, and K. D. Phillips.
2007. Socio-communicative deﬁcits in young children with
Williams syndrome: performance on the autism diagnostic
observation schedule. Child Neuropsychology 13:444–467.
Kobrynski, L. J., and K. E. Sullivan. 2007. Velocardiofacial
syndrome, DiGeorge syndrome: the chromosome 22q11.2
deletion syndromes. Lancet 370:1443–1452.
Konneker, T., T. Barnes, H. Furberg, M. Losh, C. M. Bulik,
and P. F. Sullivan. 2008. A searchable database of genetic
evidence for psychiatric disorders. American Journal of
Medical Genetics. Part B, Neuropsychiatric Genetics
147:671–675.
Korbel, J. O., P. M. Kim, X. Chen, A. E. Urban, S. Weissman,
M. Snyder, and M. B. Gerstein. 2008. The current excite-
ment about copy-number variation: how it relates to gene
duplications and protein families. Current Opinion in
Structural Biology 18:366–374.
Kravariti, E., T. Toulopoulou, F. Mapua-Filbey, K. Schulze,
M. Walshe, P. Sham, R. M. Murray et al. 2006. Intellectual
asymmetry and genetic liability in ﬁrst-degree relatives of
probands with schizophrenia. British Journal of Psychiatry
188:186–187.
de La Rochebrochard, C., G. Joly-He ´las, A. Goldenberg,
I. Durand, A. Laquerrie `re, V. Ickowicz, P. Saugier-Veber
Crespi et al. Genomic sister-disorders
ª 2009 The Authors
Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100 95et al. 2006. The intrafamilial variability of the 22q11.2
microduplication encompasses a spectrum from minor
cognitive deﬁcits to severe congenital anomalies. American
Journal of Medical Genetics. Part A 140:1608–1613.
Lainhart, J. E., E. D. Bigler, M. Bocian, H. Coon, E. Dinh, G.
Dawson, C. K. Deutsch et al. 2006. Head circumference and
height in autism: a study by the collaborative program of
excellence in autism. American Journal of Medical Genetics.
Part A 140:2257–2274.
Lajiness-O’Neill, R., I. Beaulieu, A. Asamoah, J. B. Titus, E.
Bawle, S. Ahmad, J. W. Kirk et al. 2006. The neuropsycho-
logical phenotype of velocardiofacial syndrome (VCFS):
relationship to psychopathology. Archives of Clinical Neuro-
psychology 21:175–184.
Lauritsen, M., O. Mors, P. B. Mortensen, and H. Ewald. 1999.
Infantile autism and associated autosomal chromosome
abnormalities: a register-based study and a literature survey.
Journal of Child Psychology and Psychiatry, and Allied
Disciplines 40:335–345.
Lawrence, K., R. Campbell, J. Swettenham, J. Terstegge, R.
Akers, M. Coleman, and D. Skuse. 2003. Interpreting gaze in
Turner syndrome: impaired sensitivity to intention and
emotion, but preservation of social cueing. Neuropsycholo-
gia 41:894–905.
Laws, G., and D. Bishop. 2004. Pragmatic language impair-
ment and social deﬁcits in Williams syndrome: a compari-
son with Down’s syndrome and speciﬁc language
impairment. International Journal of Language & Commu-
nication Disorders 39:45–64.
Le Hellard, S., T. W. Mu ¨hleisen, S. Djurovic, J. Fernø, Z. Our-
iaghi, M. Mattheisen, C. Vasilescu et al. 2008. Polymor-
phisms in SREBF1 and SREBF2, two antipsychotic-activated
transcription factors controlling cellular lipogenesis, are
associated with schizophrenia in German and Scandinavian
samples. Molecular Psychiatry (in press).
Lencz, T., K. E. Burdick, P. DeRosse, T. V. Morgan, J. M.
Kane, R. Kucherlapati, and A. K. Malhotra. 2007a. MCPH1
is associated with risk for illness and cognitive ability in
patients with schizophrenia. Biological Psychiatry 61(Suppl.
160):609.
Lencz, T., T. V. Morgan, M. Athanasiou, B. Dain, C. R. Reed,
J. M. Kane, R. Kucherlapati et al. 2007b. Converging
evidence for a pseudoautosomal cytokine receptor gene
locus in schizophrenia. Molecular Psychiatry 12:572–
580.
Lewandowski, K. E., V. Shashi, P. M. Berry, and T. R. Kwapil.
2007. Schizophrenic-like neurocognitive deﬁcits in children
and adolescents with 22q11 deletion syndrome. American
Journal of Medical Genetics. Part B, Neuropsychiatric
Genetics 144:27–36.
Leyfer, O. T., J. Woodruff-Borden, B. P. Klein-Tasman,
J. S. Fricke, and C. B. Mervis. 2006. Prevalence of psychiatric
disorders in 4 to 16-year-olds with Williams syndrome.
American Journal of Medical Genetics. Part B, Neuropsychi-
atric Genetics 141:615–622.
Lincoln, A. J., Y. M. Searcy, W. Jones, and C. Lord. 2007.
Social interaction behaviors discriminate young children
with autism and Williams syndrome. Journal of the Ameri-
can Academy of Child and Adolescent Psychiatry 46:323–
331.
Liu, H., S. C. Heath, C. Sobin, J. L. Roos, B. L. Galke,
M. L. Blundell, M. Lenane et al. 2002. Genetic variation at
the 22q11 PRODH2/DGCR6 locus presents an unusual
pattern and increases susceptibility to schizophrenia.
Proceedings of the National Academy of Sciences of the
United States of America 99:3717–3722.
Liu, Y., H. Zhang, G. Ju, X. Zhang, Q. Xu, S. Liu, Y. Yu et al.
2007. A study of the PEMT gene in schizophrenia. Neurosci-
ence Letters 424:203–206.
Lynn, P. M. Y., and W. Davies. 2007. The 39,XO mouse as
a model for the neurobiology of Turner syndrome and
sex-biased neuropsychiatric disorders. Behavioural Brain
Research 179:173–182.
Marshall, C. R., A. Noor, J. B. Vincent, A. C. Lionel, L. Feuk,
J. Skaug, M. Shago et al. 2008. Structural variation of chro-
mosomes in autism spectrum disorder. American Journal of
Human Genetics 82:477–488.
Martens, M. A., S. J. Wilson, and D. C. Reutens. 2008.
Research review: Williams syndrome: a critical review of the
cognitive, behavioral, and neuroanatomical phenotype.
Journal of Child Psychology and Psychiatry, and Allied
Disciplines 49:576–608.
Martin, S. C., P. L. Wolters, and A. C. M. Smith. 2006.
Adaptive and maladaptive behavior in children with Smith-
Magenis syndrome. Journal of Autism and Developmental
Disorders 36:541–552.
Maynard, T. M., G. T. Haskell, J. A. Lieberman, and
A. LaMantia. 2002. 22q11 DS: genomic mechanisms and
gene function in DiGeorge/velocardiofacial syndrome.
International Journal of Developmental Neuroscience
20:407–419.
McCarroll, S. A., and D. M. Altshuler. 2007. Copy-number
variation and association studies of human disease. Nature
Genetics 39:s37–s42.
McClellan, J., D. Breiger, C. McCurry, and S. A. Hlastala.
2003. Premorbid functioning in early-onset psychotic
disorders. Journal of the American Academy of Child and
Adolescent Psychiatry 42:666–672.
Meechan, D. W., T. M. Maynard, D. Gopalakrishna, Y. Wu,
and A. S. LaMantia. 2007. When half is not enough: gene
expression and dosage in the 22q11 deletion syndrome.
Gene Expression 13:299–310.
Mefford, H. C., A. J. Sharp, C. Baker, A. Itsara, Z. Jiang,
K. Buysse, S. Huang et al. 2008. Recurrent rearrangements
of chromosome 1q21.1 and variable pediatric phenotypes.
New England Journal of Medicine 359:1685–1699.
Melke, J., H. Goubran Botros, P. Chaste, C. Betancur,
G. Nygren, H. Anckarsa ¨ter, M. Rastam et al. 2008. Abnor-
mal melatonin synthesis in autism spectrum disorders.
Molecular Psychiatry 13:90–98.
Genomic sister-disorders Crespi et al.
ª 2009 The Authors
96 Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100Meng, Y., Y. Zhang, V. Tregoubov, C. Janus, L. Cruz, M. Jack-
son, W. Y. Lu et al. 2002. Abnormal spine morphology and
enhanced LTP in LIMK-1 knockout mice. Neuron 35:
121–133.
Merhar, S. L., and P. Manning-Courtney. 2007. Two boys with
47, XXY and autism. Journal of Autism and Developmental
Disorders 37:840–846.
Merla, G., C. Howald, C. N. Henrichsen, R. Lyle, C. Wyss,
M. Zabot, S. E. Antonarakis et al. 2006. Submicroscopic
deletion in patients with Williams-Beuren syndrome inﬂu-
ences expression levels of the nonhemizygous ﬂanking genes.
American Journal of Human Genetics 79:332–341.
Mervis, C. B., C. A. Morris, B. P. Klein-Tasman, J. Bertrand,
S. Kwitny, L. G. Appelbaum, and C. E. Rice. 2003. Atten-
tional characteristics of infants and toddlers with Williams
syndrome during triadic interactions. Developmental
Neuropsychology 23:243–268.
Meyer-Lindenberg, A., A. R. Hariri, K. E. Munoz, C. B.
Mervis, V. S. Mattay, C. A. Morris, and K. F. Berman. 2005.
Neural correlates of genetically abnormal social cognition in
Williams syndrome. Nature Neuroscience 8:991–993.
Meyer-Lindenberg, A., C. B. Mervis, and K. F. Berman. 2006.
Neural mechanisms in Williams syndrome: a unique win-
dow to genetic inﬂuences on cognition and behaviour.
Nature Reviews. Neuroscience 7:380–393.
Miller, D. T., Y. Shen, L. A. Weiss, J. Korn, I. Anslem,
C. Bridgemohan, G. F. Cox, et al. 2008. Microdeletion /
duplication at 15q13.2q13.3 among individuals with features
of autism and other neuropsychiatric disorders. Journal of
Medical Genetics (in press).
Mills, J. L., M. L. Hediger, C. A. Molloy, G. P. Chrousos, P.
Manning-Courtney, K. F. Yu, M. Brasington et al. 2007.
Elevated levels of growth-related hormones in autism and
autism spectrum disorder. Clinical Endocrinology 67:230–
237.
Mizukami, K., J. Koizumi, H. Shiraishi, and S. Nagase. 1989.
A clinical case of Klinefelter’s syndrome with various psychi-
atric symptoms. Japanese Journal of Psychiatry and Neurol-
ogy 43:639–644.
Molina, J., P. Carmona-Mora, J. Chrast, P. M. Krall,
C. P. Canales, J. R. Lupski, A. Reymond et al. 2008.
Abnormal social behaviors and altered gene expression rates
in a mouse model for Potocki-Lupski syndrome. Human
Molecular Genetics 17:2486–2495.
Molko, N., A. Cachia, D. Riviere, J. F. Mangin, M. Bruandet,
D. LeBihan, L. Cohen et al. 2004. Brain anatomy in Turner
syndrome: evidence for impaired social and spatial-numeri-
cal networks. Cerebral Cortex 14:840–850.
Money, J. 1993. Speciﬁc neuro-cognitive impairments associ-
ated with Turner (45,X) and Klinefelter (47,XXY)
syndromes: a review. Social Biology 40:147–151.
Moog, U., J. J. Engelen, B. W. Weber, M. Van Gelderen,
J. Steyaert, F. Baas, H. M. Sijstermans et al. 2004. Hereditary
motor and sensory neuropathy (HMSN) IA, developmental
delay and autism related disorder in a boy with duplication
(17)(p11.2p12). Genetic Counseling 15:73–80.
Mors, O., P. B. Mortensen, and H. Ewald. 2001. No evidence
of increased risk for schizophrenia or bipolar affective disor-
der in persons with aneuploidies of the sex chromosomes.
Psychological Medicine 31:425–430.
Mraz, K. D., J. Green, T. Dumont-Mathieu, S. Makin, and
D. Fein. 2007. Correlates of head circumference growth in
infants later diagnosed with autism spectrum disorders.
Journal of Child Neurology 22:700–713.
Mukaddes, N. M., and S. Herguner. 2007. Autistic disorder
and 22q11.2 duplication. World Journal of Biological
Psychiatry 8:127–130.
Mulle, J. G. 2008. Genomic structural variation and
schizophrenia. Current Psychiatry Reports 10:171–177.
Murphy, K. C. 2002. Schizophrenia and velo-cardio-facial
syndrome. Lancet 359:426–430.
Nakamura, K., A. Anitha, K. Yamada, M. Tsujii, Y. Iwayama,
E. Hattori, T. Toyota et al. 2008. Genetic and expression
analyses reveal elevated expression of syntaxin 1A (STX1A)
in high functioning autism. International Journal of
Neuropsychopharmacology 2:1–12.
Newman, T. M., D. Macomber, A. J. Naples, T. Babitz, F.
Volkmar, and E. L. Grigorenko. 2007. Hyperlexia in children
with autism spectrum disorders. Journal of Autism and
Developmental Disorders 37:760–774.
Nguyen, D., C. Webber, and C. P. Ponting. 2006. Bias of selec-
tion on human copy-number variants. Plos Genetics 2:e20.
Nguyen, D. Q., C. P. Webber, J. Hehir-Kwa, R. Pfundt,
J. Veltman, and C. P. Ponting. 2008. Reduced purifying
selection prevails over positive selection in human copy
number variant evolution. Genome Research 18:1711–1723.
Niemi, L. T., J. M. Suvisaari, J. K. Haukka, and J. K. Lo ¨nnq-
vist. 2005. Childhood growth and future development of
psychotic disorder among Helsinki high-risk children.
Schizophrenia Research 76:105–112.
Nijhuis-van der Sanden, M. W. G., P. A. T. M. Eling, and
B. J. Otten. 2003. A review of neuropsychological and motor
studies in Turner syndrome. Neuroscience and Biobehavioral
Reviews 27:329–338.
Niklasson, L., P. Rasmussen, S. Oskarsdo ´ttir, and C. Gillberg.
2001. Neuropsychiatric disorders in the 22q11 deletion
syndrome. Genetics in Medicine 3:79–84.
Nilsson, E., G. Sta ˚lberg, P. Lichtenstein, S. Cnattingius,
P. O. Olausson, and C. M. Hultman. 2005. Fetal growth
restriction and schizophrenia: a Swedish twin study. Twin
Research and Human Genetics 8:402–408.
O’Driscoll, M., W. B. Dobyns, J. M. van Hagen, and P. A.
Jeggo. 2007. Cellular and clinical impact of haploinsufﬁcien-
cy for genes involved in ATR signaling. American Journal of
Human Genetics 81:77–86.
Ogdie, M. N., I. L. Macphie, S. L. Minassian, M. Yang,
S. E. Fisher, C. Francks, R. M. Cantor et al. 2003. A ge-
nomewide scan for attention-deﬁcit/hyperactivity disorder in
Crespi et al. Genomic sister-disorders
ª 2009 The Authors
Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100 97an extended sample: suggestive linkage on 17p11. American
Journal of Human Genetics 72:1268–1279.
Orellana, C., J. Bernabeu, S. Monfort, M. Rosello ´, S. Oltra,
I. Ferrer, R. Quiroga et al. 2008. Duplication of the Wil-
liams-Beuren critical region: case report and further delinea-
tion of the phenotypic spectrum. Journal of Medical
Genetics 45:187–189.
Ou, Z., J. S. Berg, H. Yonath, V. B. Enciso, D. T. Miller,
J. Picker, T. Lenzi et al. 2008. Microduplications of 22q11.2
are frequently inherited and are associated with variable
phenotypes. Genetics in Medicine 10:267–277.
Paylor, R., B. Glaser, A. Mupo, P. Ataliotis, C. Spencer,
A. Sobotka, C. Sparks et al. 2006. Tbx1 haploinsufﬁciency is
linked to behavioral disorders in mice and humans: implica-
tions for 22q11 deletion syndrome. Proceedings of the
National Academy of Sciences of the United States of Amer-
ica 103:7729–7734.
Peterson, B. S., and J. Panksepp. 2004. Biological Basis of
Childhood Neuropsychiatric Disorders. Wiley, Hoboken, NJ.
Pober, B. R., and E. M. Dykens. 1996. Williams syndrome: an
overview of medical, cognitive, and behavioral features.
Child and Adolescent Psychiatric Clinics of North America
5:929–943.
Porter, M. A., and M. Coltheart. 2005. Cognitive heterogeneity
in Williams syndrome. Developmental Neuropsychology
27:275–306.
Porter, M. A., M. Coltheart, and R. Langdon. 2007. The neu-
ropsychological basis of hypersociability in Williams and
Down syndrome. Neuropsychologia 45:2839–2849.
Portnoı ¨, M., F. Lebas, N. Gruchy, A. Ardalan, V. Biran-Mucig-
nat, V. Malan, L. Finkel et al. 2005. 22q11.2 duplication
syndrome: two new familial cases with some overlapping
features with DiGeorge/velocardiofacial syndromes. Ameri-
can Journal of Medical Genetics. Part A 137:47–51.
Potash, J. B. 2006. Carving chaos: genetics and the classiﬁca-
tion of mood and psychotic syndromes. Harvard Review of
Psychiatry 14:47–63.
Potocki, L., W. Bi, D. Treadwell-Deering, C. M. B. Carvalho,
A. Eifert, E. M. Friedman, D. Glaze et al. 2007. Characteriza-
tion of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and
delineation of a dosage-sensitive critical interval that can
convey an autism phenotype. American Journal of Human
Genetics 80:633–649.
Prasad, S. E., S. Howley, and K. C. Murphy. 2008. Candidate
genes and the behavioral phenotype in 22q11.2 deletion syn-
drome. Developmental Disabilities Research Reviews 14:26–
34.
Ratcliffe, S. G., G. E. Butler, and M. Jones. 1990. Edinburgh
study of growth and development of children with sex
chromosome abnormalities. IV. Birth Defects Original Arti-
cle Series 26:1–44.
Ratcliffe, S. G., N. Masera, H. Pan, and M. McKie. 1994. Head
circumference and IQ of children with sex chromosome
abnormalities. Developmental Medicine and Child Neurol-
ogy 36:533–544.
Redon, R., S. Ishikawa, K. R. Fitch, L. Feuk, G. H. Perry, T. D.
Andrews, H. Fiegler et al. 2006. Global variation in copy
number in the human genome. Nature 444:444–454.
Reiss, A. L., S. Eliez, J. E. Schmitt, E. Straus, Z. Lai, W. Jones,
and U. Bellugi. 2000. IV. Neuroanatomy of Williams syn-
drome: a high-resolution MRI study. Journal of Cognitive
Neuroscience 12(Suppl. 1):65–73.
Reiss, A. L., M. A. Eckert, F. E. Rose, A. Karchemskiy,
S. Kesler, M. Chang, M. F. Reynolds et al. 2004. An experi-
ment of nature: brain anatomy parallels cognition and
behavior in Williams syndrome. Journal of Neuroscience
24:5009–5015.
Revheim, N., P. D. Butler, I. Schechter, M. Jalbrzikowski,
G. Silipo, and D. C. Javitt. 2006. Reading impairment and
visual processing deﬁcits in schizophrenia. Schizophrenia
Research 87:238–245.
Riby, D. M., and P. J. B. Hancock. 2008. Viewing it differently:
social scene perception in Williams syndrome and autism.
Neuropsychologia 46:2855–2860.
Ried, K., E. Rao, K. Schiebel, and G. A. Rappold. 1998. Gene
duplications as a recurrent theme in the evolution of the
human pseudoautosomal region 1: isolation of the gene
ASMTL. Human Molecular Genetics 7:1771–1778.
van Rijn, S., A. Aleman, H. Swaab, and R. S. Kahn. 2005. Neu-
robiology of emotion and high risk for schizophrenia: role
of the amygdala and the X-chromosome. Neuroscience and
Biobehavioral Reviews 29:385–397.
van Rijn, S., A. Aleman, H. Swaab, and R. Kahn. 2006. Klinefel-
ter’s syndrome (karyotype 47,XXY) and schizophrenia-spec-
trum pathology. British Journal of Psychiatry 189:459–460.
Ross, J. L., C. Samango-Sprouse, N. Lahlou, K. Kowal, F. F.
Elder, and A. Zinn. 2005. Early androgen deﬁciency in
infants and young boys with 47,XXY Klinefelter syndrome.
Hormone Research 64:39–45.
Ross, J., D. Roeltgen, and A. Zinn. 2006. Cognition and the
sex chromosomes: studies in Turner syndrome. Hormone
Research 65:47–56.
Rovet, J. 2004. Turner syndrome: a review of genetic and
hormonal inﬂuences on neuropsychological functioning.
Child Neuropsychology 10:262–279.
Russell, H. F., D. Wallis, M. M. M. Mazzocco, T. Moshang,
E. Zackai, A. R. Zinn, J. L. Ross et al. 2006. Increased
prevalence of ADHD in Turner syndrome with no evidence of
imprinting effects. Journal of Pediatric Psychology 31:945–
955.
Sacco, R., R. Militerni, A. Frolli, C. Bravaccio, A. Gritti, M.
Elia, P. Curatolo et al. 2007. Clinical, morphological, and
biochemical correlates of head circumference in autism.
Biological Psychiatry 62:1038–1047.
Sarimski, K. 2004. Communicative competence and behaviour-
al phenotype in children with Smith-Magenis syndrome.
Genetic Counseling 15:347–355.
Schmitt, J. E., S. Eliez, I. S. Warsofsky, U. Bellugi, and A. L.
Reiss. 2001. Enlarged cerebellar vermis in Williams
syndrome. Journal of Psychiatric Research 35:225–229.
Genomic sister-disorders Crespi et al.
ª 2009 The Authors
98 Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100Sebat, J., B. Lakshmi, D. Malhotra, J. Troge, C. Lese-Martin,
T. Walsh, B. Yamrom et al. 2007. Strong association of de
novo copy number mutations with autism. Science 316:445–
449.
Sha, K. 2008. A mechanistic view of genomic imprinting.
Annual Review of Genomics and Human Genetics 9:197–
216.
Shaikh, T. H., H. Kurahashi, S. C. Saitta, A. M. O’Hare, P.
Hu, B. A. Roe, D. A. Driscoll et al. 2000. Chromosome
22-speciﬁc low copy repeats and the 22q11.2 deletion
syndrome: genomic organization and deletion endpoint
analysis. Human Molecular Genetics 9:489–501.
Sharp, A. J., S. Hansen, R. R. Selzer, Z. Cheng, R. Regan,
J. A. Hurst, H. Stewart et al. 2006. Discovery of previously
unidentiﬁed genomic disorders from the duplication
architecture of the human genome. Nature Genetics
38:1038–1042.
Shelley, B. P., and M. M. Robertson. 2005. The neuropsychia-
try and multisystem features of the Smith-Magenis syn-
drome: a review. Journal of Neuropsychiatry and Clinical
Neurosciences 17:91–97.
Shelley, B. P., M. M. Robertson, and J. Turk. 2007. An
individual with Gilles de la Tourette syndrome and Smith-
Magenis microdeletion syndrome: is chromosome 17p11.2
a candidate region for Tourette syndrome putative
susceptibility genes? Journal of Intellectual Disability
Research 51:620–624.
Shifman, S., A. Levit, M. Chen, C. Chen, M. Bronstein,
A. Weizman, B. Yakir et al. 2006. A complete genetic
association scan of the 22q11 deletion region and functional
evidence reveal an association between DGCR2 and
schizophrenia. Human Genetics 120:160–170.
Simon, T. J., C. E. Bearden, D. M. Mc-Ginn, and E. Zackai.
2005a. Visuospatial and numerical cognitive deﬁcits in
children with chromosome 22q11.2 deletion syndrome.
Cortex 41:145–155.
Simon, T. J., J. P. Bish, C. E. Bearden, L. Ding, S. Ferrante,
V. Nguyen, J. C. Gee et al. 2005b. A multilevel analysis of
cognitive dysfunction and psychopathology associated with
chromosome 22q11.2 deletion syndrome in children.
Development and Psychopathology 17:753–784.
Simpson, J. L., F. de la Cruz, R. S. Swerdloff, C. Samango-
Sprouse, N. E. Skakkebaek, J. M. Graham Jr, T. Hassold
et al. 2003. Klinefelter syndrome: expanding the phenotype
and identifying new research directions. Genetics in Medi-
cine 5:460–468.
Skuse, D. H. 2000. Imprinting, the X-chromosome, and the
male brain: explaining sex differences in the liability to
autism. Pediatric Research 47:9–16.
Skuse, D. H. 2005. X-linked genes and mental functioning.
Human Molecular Genetics 14:r27–r32.
Skuse, D. H., R. S. James, D. V. Bishop, B. Coppin, P. Dalton,
G. Aamodt-Leeper, M. Bacarese-Hamilton et al. 1997.
Evidence from Turner’s syndrome of an imprinted X-linked
locus affecting cognitive function. Nature 387:705–708.
Smith, A. C., E. Dykens, and F. Greenberg. 1998. Behavioral
phenotype of Smith-Magenis syndrome (del 17p11.2).
American Journal of Medical Genetics 81:179–185.
Smith, A. C. M., R. E. Magenis, and S. H. Elsea. 2005. Over-
view of Smith-Magenis syndrome. Journal of the Association
of Genetic Technologists 31:163–167.
S o m e r v i l l e ,M .J . ,C .B .M e r v i s ,E .J .Y o u n g ,E .S e o ,M .d e lC a m p o ,
S. Bamforth, E. Peregrine et al. 2005. Severe expressive-language
delay related to duplication of the Williams-Beuren locus.
New England Journal of Medicine 353:1694–1701.
Stanﬁeld, A. C., A. M. McIntosh, M. D. Spencer, R. Philip, S.
Gaur, and S. M. Lawrie. 2008. Towards a neuroanatomy of
autism: a systematic review and meta-analysis of structural
magnetic resonance imaging studies. European Psychiatry
23:289–299.
Stankiewicz, P., and J. R. Lupski. 2002. Genome architecture,
rearrangements and genomic disorders. Trends in Genetics
18:74–82.
Stranger, B. E., M. S. Forrest, M. Dunning, C. E. Ingle,
C. Beazley, N. Thorne, R. Redon et al. 2007. Relative impact
of nucleotide and copy number variation on gene expression
phenotypes. Science 315:848–853.
Sugie, Y., H. Sugie, T. Fukuda, and M. Ito. 2005. Neonatal fac-
tors in infants with autistic disorder and typically developing
infants. Autism 9:487–494.
Sugihara, G., K. J. Tsuchiya, and N. Takei. 2008. Distinguish-
ing broad autism phenotype from schizophrenia-spectrum
disorders. Jounal of Autism and Developmental Disorders
358:667–675.
Sullivan, K., and H. Tager-Flusberg. 1999. Second-order belief
attribution in Williams syndrome: intact or impaired? Amer-
ican Journal of Mental Retardation 104:523–532.
Sun, S., F. Wang, J. Wei, L. Y. Cao, G. Y. Wu, L. Lu,
T. A. Kosten et al. 2008. Association between interleukin-3
receptor alpha polymorphism and schizophrenia in the
Chinese population. Neuroscience Letters 440:35–37.
Sybert, V. P., and E. McCauley. 2004. Turner’s syndrome. New
England Journal of Medicine 351:1227–1238.
Tager-Flusberg, H., and K. Sullivan. 2000. A componential
view of theory of mind: evidence from Williams syndrome.
Cognition 76:59–90.
Tassabehji, M. 2003. Williams-Beuren syndrome: a challenge
for genotype-phenotype correlations. Human Molecular
Genetics 12:r229–r237.
Temple, C. M. 2006. Developmental and acquired dyslexias.
Cortex 42:898–910.
Temple, C. M., and R. Carney. 1996. Reading skills in children
with Turner’s syndrome: an analysis of hyperplexia. Cortex
32:335–345.
Trikalinos, T. A., A. Karvouni, E. Zintzaras, T. Ylisaukko-oja,
L. Peltonen, I. Ja ¨rvela ¨, and J. P. A. Ioannidis. 2006. A heter-
ogeneity-based genome search meta-analysis for autism-
spectrum disorders. Molecular Psychiatry 11:29–36.
Turecki, G., P. Grof, E. Grof, V. D’Souza, L. Lebuis,
C. Marineau, P. Cavazzoni et al. 2001. Mapping susceptibil-
Crespi et al. Genomic sister-disorders
ª 2009 The Authors
Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100 99ity genes for bipolar disorder: a pharmacogenetic approach
based on excellent response to lithium. Molecular Psychiatry
6:570–578.
Van Den Bogaert, A., J. Del-Favero, and C. Van Broeckhoven.
2006. Major affective disorders and schizophrenia: a
common molecular signature? Human Mutation 27:833–
853.
Varrela, J. 1984. Effects of X chromosome on size and shape
of body: an anthropometric investigation in 47,XXY males.
American Journal of Physical Anthropology 64:233–242.
Vawter, M. P., P. D. Harvey, and L. E. DeLisi. 2007. Dysregu-
lation of X-linked gene expression in Klinefelter’s syndrome
and association with verbal cognition. American Journal of
Medical Genetics. Part B, Neuropsychiatric Genetics
144:728–734.
Vicari, S., E. Bates, M. C. Caselli, P. Pasqualetti, C. Gagliardi,
F. Tonucci, and V. Volterra. 2004. Neuropsychological
proﬁle of Italians with Williams syndrome: an example of a
dissociation between language and cognition? Journal of the
International Neuropsychological Society 10:862–876.
Vogels, A., W. M. A. Verhoeven, S. Tuinier, K. DeVriendt, A.
Swillen, L. M. G. Curfs, and J. P. Frijns. 2002. The psycho-
pathological phenotype of velo-cardio-facial syndrome.
Annales De Ge ´ne ´tique 45:89–95.
Voight, B. F., S. Kudaravalli, X. Wen, and J. K. Pritchard.
2006. A map of recent positive selection in the human
genome. Plos Biology 4:e72.
Vorstman, J. A. S., W. G. Staal, E. van Daalen, H. van Enge-
land, P. F. R. Hochstenbach, and L. Franke. 2006. Identiﬁca-
tion of novel autism candidate regions through analysis of
reported cytogenetic abnormalities associated with autism.
Molecular Psychiatry 11:18–28.
Wahlbeck, K., T. Forse ´n, C. Osmond, D. J. Barker, and
J. G. Eriksson. 2001. Association of schizophrenia with
low maternal body mass index, small size at birth, and
thinness during childhood. Archives of General Psychiatry
58:48–52.
Weiss, L. A., S. Purcell, S. Waggoner, K. Lawrence, D. Spektor,
M. J. Daly, P. Sklar et al. 2007. Identiﬁcation of EFHC2 as a
quantitative trait locus for fear recognition in Turner syn-
drome. Human Molecular Genetics 16:107–113.
Weiss, L. A., Y. Shen, J. M. Korn, D. E. Arking, D. T. Miller,
R. Fossdal, E. Saemundsen et al. 2008. Association between
microdeletion and microduplication at 16p11.2 and autism.
New England Journal of Medicine 358:667–675.
Williams, N. M., N. Norton, H. Williams, B. Ekholm, M. L.
Hamshere, Y. Lindblom, K. V. Chowdari et al. 2003. A sys-
tematic genomewide linkage study in 353 sib pairs with
schizophrenia. American Journal of Human Genetics
73:1355–1367.
Williams, N. M., B. Glaser, N. Norton, H. Williams, T. Pierce,
V. Moskvina, S. Monks et al. 2008. Strong evidence that
GNB1L is associated with schizophrenia. Human Molecular
Genetics 17:555–566.
Wong, A. H. C., J. Trakalo, O. Likhodi, M. Yusuf, A. Macedo,
M. Azevedo, T. Klempan et al. 2004. Association between
schizophrenia and the syntaxin 1A gene. Biological
Psychiatry 56:24–29.
Wonodi, I., L. E. Hong, M. T. Avila, R. W. Buchanan, W. T.
Carpenter, O. C. Stine, B. D. Mitchell et al. 2005. Association
between polymorphism of the SNAP29 gene promoter region
and schizophrenia. Schizophrenia Research 78:339–341.
Ylisaukko-oja, T., M. Alarco ´n, R. M. Cantor, M. Auranen, R.
Vanhala, E. Kempas, L. von Wendt et al. 2006. Search for
autism loci by combined analysis of Autism Genetic
Resource Exchange and Finnish families. Annals of Neurol-
ogy 59:145–155.
Yobb, T. M., M. J. Somerville, L. Willatt, H. V. Firth,
K. Harrison, J. MacKenzie, N. Gallo et al. 2005. Microdupli-
cation and triplication of 22q11.2: a highly variable syn-
drome. American Journal of Human Genetics 76:865–876.
Young, E. J., T. Lipina, E. Tam, A. Mandel, S. J. Clapcote, A.
R. Bechard, J. Chambers et al. 2008. Reduced fear and
aggression and altered serotonin metabolism in Gtf2ird1-
targeted mice. Genes, Brain, and Behavior 7:224–234.
Zhang, J., R. Nielsen, and Z. Yang. 2005. Evaluation of an
improved branch-site likelihood method for detecting posi-
tive selection at the molecular level. Molecular Biology and
Evolution 22:2472–2479.
Zinkstok, J., and T. van Amelsvoort. 2005. Neuropsychological
proﬁle and neuroimaging in patients with 22Q11.2 deletion
syndrome: a review. Child Neuropsychology 11:21–37.
Zinn, A. R., D. Roeltgen, G. Stefanatos, P. Ramos, F. F. Elder,
H. Kushner, K. Kowal et al. 2007. A Turner syndrome neu-
rocognitive phenotype maps to Xp22.3. Behavioral and
Brain Functions 3:24.
Zuberbu ¨hler, K. 2006. Language evolution: the origin of mean-
ing in primates. Current Biology 16:R123–R125.
Zutshi, A., Y. C. J. Reddy, K. Thennarasu, and C. R. Chandr-
ashekhar. 2006. Comorbidity of anxiety disorders in patients
with remitted bipolar disorder. European Archives of Psychi-
atry and Clinical Neuroscience 256:428–436.
Zweier, C., H. Sticht, I. Aydin-Yaylagu ¨l, C. E. Campbell, and
A. Rauch. 2007. Human TBX1 missense mutations cause
gain of function resulting in the same phenotype as 22q11.2
deletions. American Journal of Human Genetics 80:510–517.
Genomic sister-disorders Crespi et al.
ª 2009 The Authors
100 Journal compilation ª 2009 Blackwell Publishing Ltd 2 (2009) 81–100